<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Breast cancer,Tumors,Tumors,2006,2007,Abortion-breast cancer hypothesis,Adenocarcinoma,Adenoma,Alcohol and cancer,Aluminum,American Cancer Society" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Breast cancer - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Breast cancer</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table class="infobox" style="width: 200px; font-size: 95%; text-align: left;">
<caption style="background: lightgrey; font-size: 95%;"><b>Breast cancer</b><br />
<i>Classification &amp; external resources</i></caption>
<tr>
<th><a href="../../../i/c/d/ICD_10d0.html" title="ICD">ICD</a>-<a href="../../../l/i/s/List_of_ICD-10_codes_1183.html" title="List of ICD-10 codes">10</a></th>
<td><a href="../../../i/c/d/ICD-10_Chapter_C_7ba1.html" title="ICD-10 Chapter C">C</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gc50.htm+c50" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gc50.htm+c50" rel="nofollow">50.</a></td>
</tr>
<tr>
<th><a href="../../../i/c/d/ICD_10d0.html" title="ICD">ICD</a>-<a href="../../../l/i/s/List_of_ICD-9_codes_cdaa.html" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=174" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=174" rel="nofollow">174</a>-<a href="http://www.icd9data.com/getICD9Code.ashx?icd9=175" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=175" rel="nofollow">175</a></td>
</tr>
<tr>
<th><a href="../../../o/m/i/OMIM_6457.html" title="OMIM">OMIM</a></th>
<td><a href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=114480" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=114480" rel="nofollow">114480</a></td>
</tr>
<tr>
<th><a href="../../../d/i/s/Diseases_Database_9859.html" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb1598.htm" class="external text" title="http://www.diseasesdatabase.com/ddb1598.htm" rel="nofollow">1598</a></td>
</tr>
<tr>
<th><a href="../../../m/e/d/MedlinePlus_0b70.html" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000913.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000913.htm" rel="nofollow">000913</a></td>
</tr>
<tr>
<th><a href="../../../e/m/e/EMedicine_a89c.html" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic2808.htm" class="external text" title="http://www.emedicine.com/med/topic2808.htm" rel="nofollow">med/2808</a>&#160;</td>
</tr>
</table>
<p><b>Breast cancer</b> is a <a href="../../../c/a/n/Cancer.html" title="Cancer">cancer</a> of the <a href="../../../b/r/e/Breast.html" title="Breast">breast</a> tissue. Worldwide, it is the most common form of cancer in females - affecting, at some time in their lives, approximately one out of thirty-nine<sup id="_ref-indy_0" class="reference"><a href="#_note-indy" title="">[1]</a></sup> to one out of three <a href="../../../w/o/m/Woman.html" title="Woman">women</a> who reach age ninety in the Western world. It is the second most fatal cancer in women (after <a href="../../../l/u/n/Lung_cancer.html" title="Lung cancer">lung cancer</a>), and the number of cases has significantly increased since the 1970s, a phenomenon partly blamed on modern lifestyles in the Western world.<sup id="_ref-indy_1" class="reference"><a href="#_note-indy" title="">[1]</a></sup><sup id="_ref-0" class="reference"><a href="#_note-0" title="">[2]</a></sup> Because the breast is composed of identical tissues in males and females, breast cancer also occurs in males, though it is far less common.<sup id="_ref-Dave_0" class="reference"><a href="#_note-Dave" title="">[3]</a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History_of_breast_cancer"><span class="tocnumber">1</span> <span class="toctext">History of breast cancer</span></a></li>
<li class="toclevel-1"><a href="#Types_of_breast_cancer"><span class="tocnumber">2</span> <span class="toctext">Types of breast cancer</span></a></li>
<li class="toclevel-1"><a href="#Epidemiologic_risk_factors_and_etiology"><span class="tocnumber">3</span> <span class="toctext">Epidemiologic risk factors and etiology</span></a>
<ul>
<li class="toclevel-2"><a href="#Age"><span class="tocnumber">3.1</span> <span class="toctext">Age</span></a></li>
<li class="toclevel-2"><a href="#Alcohol"><span class="tocnumber">3.2</span> <span class="toctext">Alcohol</span></a></li>
<li class="toclevel-2"><a href="#Environmental_causes"><span class="tocnumber">3.3</span> <span class="toctext">Environmental causes</span></a></li>
<li class="toclevel-2"><a href="#Genes"><span class="tocnumber">3.4</span> <span class="toctext">Genes</span></a></li>
<li class="toclevel-2"><a href="#Hormones"><span class="tocnumber">3.5</span> <span class="toctext">Hormones</span></a></li>
<li class="toclevel-2"><a href="#Light_levels"><span class="tocnumber">3.6</span> <span class="toctext">Light levels</span></a></li>
<li class="toclevel-2"><a href="#Obesity"><span class="tocnumber">3.7</span> <span class="toctext">Obesity</span></a></li>
<li class="toclevel-2"><a href="#Unproven"><span class="tocnumber">3.8</span> <span class="toctext">Unproven</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prevention_in_high-risk_individuals"><span class="tocnumber">4</span> <span class="toctext">Prevention in high-risk individuals</span></a></li>
<li class="toclevel-1"><a href="#Prevention_of_environmental_causes"><span class="tocnumber">5</span> <span class="toctext">Prevention of environmental causes</span></a></li>
<li class="toclevel-1"><a href="#Symptoms"><span class="tocnumber">6</span> <span class="toctext">Symptoms</span></a></li>
<li class="toclevel-1"><a href="#Screening"><span class="tocnumber">7</span> <span class="toctext">Screening</span></a></li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">8</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">9</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Surgery"><span class="tocnumber">9.1</span> <span class="toctext">Surgery</span></a></li>
<li class="toclevel-2"><a href="#Radiation_therapy"><span class="tocnumber">9.2</span> <span class="toctext">Radiation therapy</span></a>
<ul>
<li class="toclevel-3"><a href="#Indications_for_radiation"><span class="tocnumber">9.2.1</span> <span class="toctext">Indications for radiation</span></a></li>
<li class="toclevel-3"><a href="#Types_of_radiotherapy"><span class="tocnumber">9.2.2</span> <span class="toctext">Types of radiotherapy</span></a></li>
<li class="toclevel-3"><a href="#Side_effects_of_radiation_therapy"><span class="tocnumber">9.2.3</span> <span class="toctext">Side effects of radiation therapy</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Systemic_therapy"><span class="tocnumber">9.3</span> <span class="toctext">Systemic therapy</span></a>
<ul>
<li class="toclevel-3"><a href="#Chemotherapy"><span class="tocnumber">9.3.1</span> <span class="toctext">Chemotherapy</span></a></li>
<li class="toclevel-3"><a href="#Hormonal_treatment"><span class="tocnumber">9.3.2</span> <span class="toctext">Hormonal treatment</span></a></li>
<li class="toclevel-3"><a href="#Targeted_therapy"><span class="tocnumber">9.3.3</span> <span class="toctext">Targeted therapy</span></a></li>
<li class="toclevel-3"><a href="#Preclinical"><span class="tocnumber">9.3.4</span> <span class="toctext">Preclinical</span></a>
<ul>
<li class="toclevel-4"><a href="#Flax_seeds"><span class="tocnumber">9.3.4.1</span> <span class="toctext">Flax seeds</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-2"><a href="#Alternative_medicine"><span class="tocnumber">9.4</span> <span class="toctext">Alternative medicine</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prognosis"><span class="tocnumber">10</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1"><a href="#Breast_cancer_in_males"><span class="tocnumber">11</span> <span class="toctext">Breast cancer in males</span></a></li>
<li class="toclevel-1"><a href="#Breast_cancer_metastasis"><span class="tocnumber">12</span> <span class="toctext">Breast cancer metastasis</span></a></li>
<li class="toclevel-1"><a href="#Breast_cancer_awareness"><span class="tocnumber">13</span> <span class="toctext">Breast cancer awareness</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">14</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">15</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">16</span> <span class="toctext">External links</span></a>
<ul>
<li class="toclevel-2"><a href="#General"><span class="tocnumber">16.1</span> <span class="toctext">General</span></a></li>
<li class="toclevel-2"><a href="#Research_and_statistics"><span class="tocnumber">16.2</span> <span class="toctext">Research and statistics</span></a></li>
<li class="toclevel-2"><a href="#Clinical"><span class="tocnumber">16.3</span> <span class="toctext">Clinical</span></a></li>
<li class="toclevel-2"><a href="#Other"><span class="tocnumber">16.4</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="History_of_breast_cancer" id="History_of_breast_cancer"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: History of breast cancer">edit</a>]</span> <span class="mw-headline">History of breast cancer</span></h2>
<p>Breast cancer may be one of the oldest known forms of cancer tumors in humans. The oldest description of cancer (although the term cancer was not used) was discovered in Egypt and dates back to approximately 1600 BC. The <a href="../../../e/d/w/Edwin_Smith_Papyrus_7465.html" title="Edwin Smith Papyrus">Edwin Smith Papyrus</a> describes 8 cases of tumors or ulcers of the breast that were treated by <a href="../../../c/a/u/Cauterization.html" title="Cauterization">cauterization</a>, with a tool called "the fire drill." The writing says about the disease, "There is no treatment."<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[4]</a></sup> At least one of the described cases is male. For centuries, physicians described similar cases in their practises, with the same sad conclusion. It wasn't until doctors achieved greater understanding of the circulatory system in the 17th century that they could establish a link between breast cancer and the <a href="../../../l/y/m/Lymph_nodes.html" title="Lymph nodes">lymph nodes</a> in the armpit. The French surgeon <a href="../../../j/e/a/Jean_Louis_Petit_f329.html" title="Jean Louis Petit">Jean Louis Petit</a> (1674-1750) and later the Scottish surgeon <a href="../../../b/e/n/Benjamin_Bell_19a3.html" title="Benjamin Bell">Benjamin Bell</a> (1749-1806) were the first to remove the lymph nodes, breast tissue, and underlying chest muscle. Their successful work was carried on by <a href="../../../w/i/l/William_Stewart_Halsted_f729.html" title="William Stewart Halsted">William Stewart Halsted</a> who started performing <a href="../../../r/a/d/Radical_mastectomy.html" title="Radical mastectomy">mastectomies</a> in 1882. He became known for his <a href="../../../r/a/d/Radical_mastectomy.html" title="Radical mastectomy">Halsted radical mastectomy</a>, a surgical procedure that remained popular up to the 1970s.</p>
<p><a name="Types_of_breast_cancer" id="Types_of_breast_cancer"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Types of breast cancer">edit</a>]</span> <span class="mw-headline">Types of breast cancer</span></h2>
<ul>
<li><a href="../../../d/u/c/Ductal_carcinoma.html" title="Ductal carcinoma">Ductal carcinoma</a> 65-90%</li>
<li>Lobular carcinoma 10%</li>
<li><a href="../../../i/n/f/Inflammatory_breast_cancer.html" title="Inflammatory breast cancer">Inflammatory breast cancer</a></li>
<li>Medullary carcinoma 5%</li>
<li>Colloid carcinoma 2%</li>
<li>Papillary carcinoma 1%</li>
<li>Metaplastic carcinoma</li>
</ul>
<p><a name="Epidemiologic_risk_factors_and_etiology" id="Epidemiologic_risk_factors_and_etiology"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Epidemiologic risk factors and etiology">edit</a>]</span> <span class="mw-headline">Epidemiologic risk factors and etiology</span></h2>
<p>It is important to have a model of <a href="../../../c/a/u/Causality.html" title="Causality">causation</a> of a disease in order to distinguish <a href="../../../e/p/i/Epidemiological.html" title="Epidemiological">epidemiological</a> risk factors or associations with disease, from the biological <a href="../../../e/t/i/Etiology.html" title="Etiology">etiology</a> and primary cause, secondary co-factors, and simple promoters of the disease. The first work on breast cancer epidemiology was done by <a href="../../../j/a/n/Janet_Lane-Claypon_8588.html" title="Janet Lane-Claypon">Janet Lane-Claypon</a>, who published a comparative study in 1926 of 500 breast cancer cases and 500 control patients of the same background and lifestyle for the British Ministry of Health.</p>
<p>Today, breast cancer, like other forms of cancer, is considered to be a result of damage to <a href="../../../d/n/a/DNA_396c.html" title="DNA">DNA</a>. How this mechanism may occur comes from several known or hypothesized factors (such as exposure to ionizing radiation, or viral mutagenesis). Some factors lead to an increased rate of mutation (exposure to estrogens) and decreased repair (the <i>BRCA1</i>, <i>BRCA2</i> and <i>p53</i>) genes. Although many epidemiological risk factors, and biological co-factors and promoters have been identified, the majority of breast cancer incidence remains unattributable, and the primary cause is unknown.</p>
<p>Dietary influences have been proposed and examined, and recent research suggests that low fat diets may significantly decrease the risk of breast cancer as well as the recurrence of breast cancer.<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[5]</a></sup> A significant environmental effect was revealed by the large difference in breast cancer incidence between countries and continents, and a migration effect which slowly increases the risk of breast cancer even across generations after migration from a country of lower incidence to a country of higher incidence, such as moving from China or Japan to the United States. Humans are not the only mammal prone to breast cancer. Some strains of mice, namely the house mouse (Mus domesticus) are prone to breast cancer which is caused by infection with the <a href="../../../m/o/u/Mouse_mammary_tumour_virus.html" title="Mouse mammary tumour virus">mouse mammary tumour virus</a> (MMTV or "Bittner virus" for its discoverer Hans Bittner), by random insertional mutagenesis. Suspicion of MMTV or other viruses in human breast cancer is controversial, and the idea is not generally accepted for lack of direct and definitive evidence. There is much more research in diagnosis and treatment of breast cancer than in its cause. <a name="Age" id="Age"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Age">edit</a>]</span> <span class="mw-headline">Age</span></h3>
<p>The risk of getting breast cancer increases with age. For someone who lives to the age of 90, the chances of getting breast cancer is about 14.3% or one in seven during their lifetime.<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[6]</a></sup> Men can also develop breast cancer, but their risk is less than one in 1000 (see <a href="../../../s/e/x/Sex_and_illness.html" title="Sex and illness">sex and illness</a>).<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup> This risk is modified by many different factors. In 5% of breast cancer cases, there is a strong inherited familial risk.<sup id="_ref-Albright_0" class="reference"><a href="#_note-Albright" title="">[7]</a></sup></p>
<p>The probability of breast cancer rises with age but breast cancer tends to be more aggressive when it occurs in younger people. One type of breast cancer that is especially aggressive and disproportionately occurs in younger people is <a href="../../../i/n/f/Inflammatory_breast_cancer.html" title="Inflammatory breast cancer">inflammatory breast cancer</a>. It is initially <a href="../../../c/a/n/Cancer_staging.html" title="Cancer staging">staged</a> as Stage IIIb or Stage IV. It also is unique because it often does not present with a lump so that it often is not detected by <a href="../../../m/a/m/Mammography.html" title="Mammography">mammography</a> or <a href="../../../m/e/d/Medical_ultrasonography.html" title="Medical ultrasonography">ultrasound</a>. It presents with the signs and symptoms of a breast infection like <a href="../../../m/a/s/Mastitis.html" title="Mastitis">mastitis</a>.</p>
<p><a name="Alcohol" id="Alcohol"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Alcohol">edit</a>]</span> <span class="mw-headline">Alcohol</span></h3>
<p>Alcohol generally appears to increase the risk of breast cancer. The UK's <i>Review of Alcohol: Association with Breast Cancer</i> concludes that "studies confirm previous observations that there appears to be an association between alcohol intake and increased risk of breast cancer in women. On balance, there was a weak association between the amount of alcohol consumed and the relative risk."<sup id="_ref-UKDOH_Alcohol_0" class="reference"><a href="#_note-UKDOH_Alcohol" title="">[8]</a></sup></p>
<p>The National Institute on Alcohol Abuse and Alcoholism (NIAAA) concludes that "Chronic alcohol consumption has been associated with a small (averaging 10 percent) increase in a woman's risk of breast cancer.<sup id="_ref-Friedenreich_1993_0" class="reference"><a href="#_note-Friedenreich_1993" title="">[9]</a></sup><sup id="_ref-Longnecker_1988_0" class="reference"><a href="#_note-Longnecker_1988" title="">[10]</a></sup><sup id="_ref-Longnecker_1992_0" class="reference"><a href="#_note-Longnecker_1992" title="">[11]</a></sup><sup id="_ref-Nasca_1990_0" class="reference"><a href="#_note-Nasca_1990" title="">[12]</a></sup> According to these studies, the risk appears to increase as the quantity and duration of alcohol consumption increases. Other studies, however, have found no evidence of such a link.<sup id="_ref-Chu_1989_0" class="reference"><a href="#_note-Chu_1989" title="">[13]</a></sup><sup id="_ref-Schatzkin_1989_0" class="reference"><a href="#_note-Schatzkin_1989" title="">[14]</a></sup><sup id="_ref-Webster_1983_0" class="reference"><a href="#_note-Webster_1983" title="">[15]</a></sup></p>
<p>The <i>Committee on Carcinogenicity of Chemicals in Food, Consumer Products Non-Technical Summary</i> concludes, "the new research estimates that a woman drinking an average of two units of alcohol per day has a lifetime risk of developing breast cancer 19% higher than a woman who drinks an average of one unit of alcohol per day.<sup id="_ref-UKDOH_Chemicals_0" class="reference"><a href="#_note-UKDOH_Chemicals" title="">[16]</a></sup> The risk of breast cancer further increases with each additional drink consumed per day. The research also concludes that approximately 6% (between 3.2% and 8.8%) of breast cancers reported in the UK each year could be prevented if drinking was reduced to a very low level (i.e. less than 1 unit/week)."</p>
<p>It has been reported that "two drinks daily increase the risk of getting breast cancer by about 25 percent" (NCI), but the evidence is inconsistent. The Framingham study has carefully tracked individuals since the 1940s. Data from that research found that drinking alcohol moderately did not increase breast cancer risk (Wellness Facts). Similarly, research by the Danish National Institute for Public Health found that moderate drinking had virtually no effect on breast cancer risk.<sup id="_ref-Petri_2004_0" class="reference"><a href="#_note-Petri_2004" title="">[17]</a></sup></p>
<p>Breast cancer constitutes about 7.3% of all cancers.<sup id="_ref-ACS_2007_0" class="reference"><a href="#_note-ACS_2007" title="">[18]</a></sup> Among women, breast cancer comprises 60% of alcohol-attributable cancers.<sup id="_ref-Boffetta_2006_0" class="reference"><a href="#_note-Boffetta_2006" title="">[19]</a></sup> One study suggests that women who frequently drink red wine may have an increased risk of developing breast cancer.<sup id="_ref-Maggiolini_2005_0" class="reference"><a href="#_note-Maggiolini_2005" title="">[20]</a></sup></p>
<p>"Folate intake counteracts breast cancer risk associated with alcohol consumption"<sup id="_ref-4" class="reference"><a href="#_note-4" title="">[21]</a></sup> and "women who drink alcohol and have a high folate intake are not at increased risk of cancer."<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[22]</a></sup> Those who have a high (200 micrograms or more per day) level of <a href="../../../f/o/l/Folate.html" title="Folate">folate</a> (folic acid or Vitamin B9) in their diet are not at increased risk of breast cancer compared to those who abstain from alcohol.<sup id="_ref-Zhang_1999_0" class="reference"><a href="#_note-Zhang_1999" title="">[23]</a></sup> Foods rich in folate include <a href="../../../c/i/t/Citrus_fruit.html" title="Citrus fruit">citrus fruits</a>, citrus juices, dark <a href="../../../g/r/e/Green_leafy_vegetable.html" title="Green leafy vegetable">green leafy vegetables</a> (such as <a href="../../../s/p/i/Spinach.html" title="Spinach">spinach</a>), dried <a href="../../../b/e/a/Bean.html" title="Bean">beans</a>, and <a href="../../../p/e/a/Pea.html" title="Pea">peas</a>. Vitamin B9 can also be taken in a multivitamin pill.</p>
<p><a name="Environmental_causes" id="Environmental_causes"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Environmental causes">edit</a>]</span> <span class="mw-headline">Environmental causes</span></h3>
<p>All women and men are at risk for breast cancer, regardless of hereditary factors. In fact, 85 to 90 percent of breast cancer incidences cannot be explained by inherited genetic predisposition. Other known risk factors and personal characteristics include personal or family history of breast cancer, high breast tissue density, earlier onset of menstruation (12 years or younger), later menopause (55 years or older), late first-term pregnancy (35 years or older), no children or no breast-feeding, early or recent use of oral contraceptives, more than four years use of hormone replacement therapy, postmenopausal obesity, alcohol consumption, exposures to secondhand cigarette smoke and exposure to ionizing radiation.<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[24]</a></sup></p>
<p>When all known risk factors and characteristics are added together including genetics and family history, as much as 50 percent of breast cancer cases remain unexplained.<sup id="_ref-7" class="reference"><a href="#_note-7" title="">[25]</a></sup></p>
<p>Although environmental exposures are not generally cited as risk factors for the disease (except for diet, pharmaceuticals and radiation), a substantial and growing body of evidence indicates that exposures to certain toxic chemicals and hormone-mimicking compounds including chemicals used in <a href="../../../p/e/s/Pesticides.html" title="Pesticides">pesticides</a>, <a href="../../../c/o/s/Cosmetics.html" title="Cosmetics">cosmetics</a> and cleaning products contribute to the development of breast cancer.</p>
<p>A recent <a href="../../../c/a/n/Canadian.html" title="Canadian">Canadian</a> study concluded that female farm workers are three times more likely to have breast cancer.<sup id="_ref-8" class="reference"><a href="#_note-8" title="">[26]</a></sup></p>
<p><a name="Genes" id="Genes"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Genes">edit</a>]</span> <span class="mw-headline">Genes</span></h3>
<p>Two autosomal dominant <a href="../../../g/e/n/Gene.html" title="Gene">genes</a>, <i><a href="../../../b/r/c/BRCA1_aa38.html" title="BRCA1">BRCA1</a></i> and <i><a href="../../../b/r/c/BRCA2_5caf.html" title="BRCA2">BRCA2</a></i>, have been linked to the rare familial form of breast cancer. People in families expressing mutations in these genes have a 60% to 80% risk of developing breast cancer according to Robbins Pathological Basis of Disease. If a mother or a sister was diagnosed breast cancer, the risk is about 2-fold higher than those women without a familial history.</p>
<p><a name="Hormones" id="Hormones"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Hormones">edit</a>]</span> <span class="mw-headline">Hormones</span></h3>
<p>Persistently increased blood levels of <a href="../../../e/s/t/Estrogen.html" title="Estrogen">estrogen</a> are associated with an increased risk of breast cancer, as are increased levels of the <a href="../../../a/n/d/Androgens.html" title="Androgens">androgens</a> <a href="../../../a/n/d/Androstenedione.html" title="Androstenedione">androstenedione</a> and <a href="../../../t/e/s/Testosterone.html" title="Testosterone">testosterone</a> (which can be directly converted by <a href="../../../a/r/o/Aromatase.html" title="Aromatase">aromatase</a> to the estrogens <a href="../../../e/s/t/Estrone.html" title="Estrone">estrone</a> and <a href="../../../e/s/t/Estradiol.html" title="Estradiol">estradiol</a>, respectively). Increased blood levels of <a href="../../../p/r/o/Progesterone.html" title="Progesterone">progesterone</a> are associated with a decreased risk of breast cancer in premenopausal women.<sup id="_ref-9" class="reference"><a href="#_note-9" title="">[27]</a></sup> A number of circumstances which increase exposure to endogenous estrogens including not having children, delaying first childbirth, not breastfeeding, early <a href="../../../m/e/n/Menarche.html" title="Menarche">menarche</a> (the first menstrual period) and late <a href="../../../m/e/n/Menopause.html" title="Menopause">menopause</a> are suspected of increasing lifetime risk for developing breast cancer.<sup id="_ref-10" class="reference"><a href="#_note-10" title="">[28]</a></sup></p>
<p><a href="../../../h/o/r/Hormonal_contraception.html" title="Hormonal contraception">Hormonal contraceptives</a> may produce a slight increase in the risk of breast cancer diagnosis among current and recent users, but this appears to be a short-term effect. In 1996 the largest collaborative reanalysis of individual data on over 150,000 women in 54 studies of breast cancer found a <a href="../../../r/e/l/Relative_risk.html" title="Relative risk">relative risk</a> (RR) of 1.24 of breast cancer diagnosis among current <a href="../../../c/o/m/Combined_oral_contraceptive_pill.html" title="Combined oral contraceptive pill">combined oral contraceptive pill</a> users; 10 or more years after stopping, no difference was seen. Further, the cancers diagnosed in women who had ever used hormonal contraceptives were less advanced than those in nonusers, raising the possibility that the small excess among users was due to increased detection.<sup id="_ref-oxford_1996a_0" class="reference"><a href="#_note-oxford_1996a" title="">[29]</a></sup><sup id="_ref-oxford_1996b_0" class="reference"><a href="#_note-oxford_1996b" title="">[30]</a></sup> The relative risk of breast cancer diagnosis associated with current and recent use of hormonal contraceptives did not appear to vary with family history of breast cancer.<sup id="_ref-hormone_0" class="reference"><a href="#_note-hormone" title="">[31]</a></sup></p>
<p>Data exist from both observational and <a href="../../../r/a/n/Randomized_clinical_trial.html" title="Randomized clinical trial">randomized clinical trials</a> regarding the association between postmenopausal <a href="../../../h/o/r/Hormone_replacement_therapy.html" title="Hormone replacement therapy">hormone replacement therapy</a> (HRT) and breast cancer. The largest meta-analysis (1997) of data from 51 observational studies, indicated a relative risk of breast cancer of 1.35 for women who had used HRT for 5 or more years after menopause. The estrogen-plus-<a href="../../../p/r/o/Progestin.html" title="Progestin">progestin</a> arm of the <a href="../../../w/o/m/Women%27s_Health_Initiative_10ab.html" title="Women's Health Initiative">Women's Health Initiative</a> (WHI), a randomized controlled trial, which randomized more than 16,000 postmenopausal women to receive combined hormone therapy or placebo, was halted early (2002) because health risks exceeded benefits. One of the adverse outcomes prompting closure was a significant increase in both total and invasive breast cancers (RR = 1.24) in women randomized to receive estrogen and progestin for an average of 5 years. HRT-related breast cancers had adverse prognostic characteristics (more advanced stages and larger tumors) compared with cancers occurring in the placebo group, and HRT was also associated with a substantial increase in abnormal mammograms. Short-term use of hormones for treatment of menopausal symptoms appears to confer little or no breast cancer risk.<sup id="_ref-hormone_1" class="reference"><a href="#_note-hormone" title="">[31]</a></sup></p>
<p><a name="Light_levels" id="Light_levels"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Light levels">edit</a>]</span> <span class="mw-headline">Light levels</span></h3>
<p>Researchers at the <a href="../../../n/a/t/National_Cancer_Institute_eeb0.html" title="National Cancer Institute">National Cancer Institute</a> and <a href="../../../n/a/t/National_Institute_of_Environmental_Health_Sciences_949d.html" title="National Institute of Environmental Health Sciences">National Institute of Environmental Health Sciences</a> have concluded a study that suggests that artificial light during the night can be a factor for breast cancer.<sup id="_ref-11" class="reference"><a href="#_note-11" title="">[32]</a></sup></p>
<p><a name="Obesity" id="Obesity"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Obesity">edit</a>]</span> <span class="mw-headline">Obesity</span></h3>
<p>Gaining weight after the menopause can increase a woman's or man's risk. Putting on 9.9kg (22lbs) increased the risk of developing breast cancer by 18%.<sup id="_ref-12" class="reference"><a href="#_note-12" title="">[33]</a></sup></p>
<p><a name="Unproven" id="Unproven"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Unproven">edit</a>]</span> <span class="mw-headline">Unproven</span></h3>
<ul>
<li>It has been hypothesized that <a href="../../../a/b/o/Abortion-breast_cancer_hypothesis.html" title="Abortion-breast cancer hypothesis">abortion</a> may increase the risk of breast cancer because of hormones in early pregnancy. Recent large studies do not support this association.<sup id="_ref-13" class="reference"><a href="#_note-13" title="">[34]</a></sup></li>
<li>Although not well quantified there has long been a concern about risk associated with environmental estrogenic compounds, such as <a href="../../../d/i/o/Dioxins.html" title="Dioxins">dioxins</a>, or <a href="../../../p/h/y/Phytoestrogens.html" title="Phytoestrogens">phytoestrogens</a> such as found in <a href="../../../s/o/y/Soy_beans.html" title="Soy beans">soy beans</a>.<sup id="_ref-14" class="reference"><a href="#_note-14" title="">[35]</a></sup></li>
<li><a href="../../../a/l/u/Aluminum.html" title="Aluminum">Aluminum</a> salts such as those used in anti-perspirants have recently been classified as metalloestrogens. In research published in the <i>Journal of Applied Toxicology</i>, Dr. Philippa D. Darbre of the <a href="../../../u/n/i/University_of_Reading_894e.html" title="University of Reading">University of Reading</a> has shown that aluminium salts increase estrogen-related gene expression in human breast cancer cells grown in the laboratory.<sup id="_ref-15" class="reference"><a href="#_note-15" title="">[36]</a></sup><sup id="_ref-16" class="reference"><a href="#_note-16" title="">[37]</a></sup><sup id="_ref-17" class="reference"><a href="#_note-17" title="">[38]</a></sup></li>
</ul>
<p><a name="Prevention_in_high-risk_individuals" id="Prevention_in_high-risk_individuals"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Prevention in high-risk individuals">edit</a>]</span> <span class="mw-headline">Prevention in high-risk individuals</span></h2>
<p>Prophylactic <a href="../../../o/o/p/Oophorectomy.html" title="Oophorectomy">oophorectomy</a> (removal of ovaries), post-child-bearing, reduces the risk of developing breast cancer by 60%, as well as reducing the risk of developing ovarian cancer by 96%.<sup id="_ref-Kauff_2002_0" class="reference"><a href="#_note-Kauff_2002" title="">[39]</a></sup> The side effects of Oophorectomy may be alleviated by medicines other than hormonal replacement. Non-hormonal biphosphonates (such as Fosamax and Actonel) increase bone strength and are available as once-a-week pills. Low-dose Selective Serotonin Reuptake Inhibitors (e.g. Paxil, Prozac) alleviate vasomotor menopausal symptoms, i.e. "hot flashes".<sup id="_ref-18" class="reference"><a href="#_note-18" title="">[40]</a></sup></p>
<p><a name="Prevention_of_environmental_causes" id="Prevention_of_environmental_causes"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Prevention of environmental causes">edit</a>]</span> <span class="mw-headline">Prevention of environmental causes</span></h2>
<p>Fewer than 20 percent of breast cancers are genetic. When all known risk factors and characteristics are added together, including family history, genetics, smoking and obesity, more than 50 percent of breast cancer cases remain unexplained.<sup id="_ref-19" class="reference"><a href="#_note-19" title="">[41]</a></sup> According to <a href="http://breastcancerfund.org/evidence" class="external text" title="http://breastcancerfund.org/evidence" rel="nofollow">State of the Evidence 2006 - What Is the Connection Between the Environment and Breast Cancer?”</a>, a report which reviews and analyzes nearly 350 journal-published scientific studies on environmental links to breast cancer:</p>
<ul>
<li>Over 100,000 synthetic chemicals are registered for use today in the United States, with an additional 1,000 new chemicals added each year, yet less than 10 percent of these chemicals have been tested for their effects on human health. Large numbers of these chemicals are found in products we come into contact with every day and compelling scientific evidence points to these chemicals as contributing to the development of breast cancer, either by altering hormone function or gene expression</li>
<li>Many toxic chemicals are now credibly linked to serious chronic diseases including breast cancer. Furthermore, new science demonstrates that even very small amounts of some chemicals can have adverse health effects, particularly in pregnant mothers, infants and small children. (See <a href="http://breastcancerfund.org/evidence" class="external text" title="http://breastcancerfund.org/evidence" rel="nofollow">State of the Evidence</a>)</li>
</ul>
<p>The <a href="http://breastcancerfund.org/" class="external text" title="http://breastcancerfund.org/" rel="nofollow">Breast Cancer Fund</a> suggests the following environmental prevention methods:</p>
<ul>
<li>Practice Healthy Purchasing: Don’t bring toxic chemicals home from the store. Choose chlorine-free paper products to reduce dioxin, a carcinogen released when chlorinated products are incinerated. Read food labels, and choose pesticide-free, organic produce and hormone-free meats and dairy products. Replace harmful household cleaners that contain bleach with cheaper, nontoxic alternatives like baking soda, borax soap and vinegar. Look for alternatives to chemical weed and bug killers— many contain toxic chemicals that accumulate in our bodies.</li>
</ul>
<ul>
<li>Use Caution with Plastics: Some plastics leach hormone-disrupting chemicals called phthalates into the substances they touch. <a href="../../../p/o/l/Polyvinyl_chloride.html" title="Polyvinyl chloride">Polyvinyl chloride</a> (PVC) plastics release <a href="../../../c/a/r/Carcinogens.html" title="Carcinogens">carcinogens</a> into our air and water during the production process. PVC plastics are especially dangerous in toys that children put in their mouths, so keep an eye out for nontoxic toys. Further, never put plastic or plastic wrap in the microwave, as this can release <a href="../../../p/h/t/Phthalates.html" title="Phthalates">phthalates</a> into food and beverages.</li>
</ul>
<ul>
<li>Advocate for Clean Air: The soot and fumes released by factories, automobiles, diesel trucks and tobacco products contain chemicals called <a href="../../../p/o/l/Polycyclic_aromatic_hydrocarbons.html" title="Polycyclic aromatic hydrocarbons">polycyclic aromatic hydrocarbons</a> (PAHs) that are linked to breast cancer. Indeed, breathing these compounds from secondhand tobacco smoke may increase your risk for breast cancer more than active smoking. Stay away from secondhand smoke, and advocate for stronger clean air protections.</li>
</ul>
<ul>
<li>Avoid Unnecessary Radiation: <a href="../../../i/o/n/Ionizing_radiation.html" title="Ionizing radiation">Ionizing radiation</a> is a known cause of breast cancer. Radiation damage to genes is cumulative over a lifetime—thus many low doses may have the same effect as a single high dose. <a href="../../../m/a/m/Mammograms.html" title="Mammograms">Mammograms</a>, other X-rays and CT scans expose you to radiation. While mammography screening may benefit postmenopausal women, mammography for women in their 30s and 40s remains controversial. Whenever you have an X-ray or scan, request a lead shield to protect the areas of your body not being X-rayed.</li>
</ul>
<ul>
<li>Explore Alternatives to Artificial <a href="../../../e/s/t/Estrogens.html" title="Estrogens">Estrogens</a>: Women who have prolonged exposure to estrogens are at higher risk for breast cancer, and major studies continue to show an increased risk when postmenopausal women use <a href="../../../h/o/r/Hormone_replacement_therapy.html" title="Hormone replacement therapy">hormone replacement therapy</a> (HRT). Women who use both birth control pills and—later in life—HRT face an even greater risk of breast cancer than those who use neither. Explore your options with healthcare professionals.</li>
</ul>
<ul>
<li>Advocate for Safe Cosmetics: Chemicals linked to cancer and birth defects do not belong in cosmetics, period. However, some popular brands of <a href="../../../s/h/a/Shampoo.html" title="Shampoo">shampoo</a>, <a href="../../../d/e/o/Deodorant.html" title="Deodorant">deodorant</a>, face cream and other everyday products contain these dangerous chemicals. The Breast Cancer Fund demands safer products and smarter laws by letting cosmetics companies know they need a makeover. The public can join BCF in asking cosmetic companies to sign the Compact for Safe Cosmetics, a pledge to substitute chemicals linked to birth defects, infertility, cancer, brain damage and other serious health consequences with safer alternatives.<sup id="_ref-20" class="reference"><a href="#_note-20" title="">[42]</a></sup></li>
</ul>
<p><a name="Symptoms" id="Symptoms"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Symptoms">edit</a>]</span> <span class="mw-headline">Symptoms</span></h2>
<p>Early breast cancer can in some cases be painful. Usually breast cancer is discovered before any symptoms are present, either on mammography or by feeling a breast lump. A lump under the arm or above the <a href="../../../c/o/l/Collarbone.html" title="Collarbone">collarbone</a> that does not go away may be present. Other possible symptoms include breast discharge, nipple inversion and changes in the skin overlying the breast<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup>.</p>
<p><a name="Screening" id="Screening"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Screening">edit</a>]</span> <span class="mw-headline">Screening</span></h2>
<p>Due to the high incidence of breast cancer among older women, screening is now recommended in many countries, the same also applies to men. Screening methods suggested include <a href="../../../b/r/e/Breast_self-examination.html" title="Breast self-examination">breast self-examination</a> and <a href="../../../m/a/m/Mammography.html" title="Mammography">mammography</a>. Mammography has been shown to reduce breast cancer-related mortality by 20-30%.<sup id="_ref-21" class="reference"><a href="#_note-21" title="">[43]</a></sup> Routine (annual) mammography of women older than 40 is encouraged as a screening method to diagnose early breast cancer and has demonstrated a protective effect in multiple clinical trials.<sup id="_ref-22" class="reference"><a href="#_note-22" title="">[44]</a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="../../../m/a/m/Image%7EMammo_breast_cancer.jpg_ea30.html" class="internal" title="Normal (left) versus cancerous (right) mammography image."><img src="../../../upload/shared/thumb/f/f6/Mammo_breast_cancer.jpg/180px-Mammo_breast_cancer.jpg" alt="Normal (left) versus cancerous (right) mammography image." width="180" height="132" longdesc="../../../m/a/m/Image%7EMammo_breast_cancer.jpg_ea30.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../m/a/m/Image%7EMammo_breast_cancer.jpg_ea30.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Normal (left) versus cancerous (right) mammography image.</div>
</div>
</div>
<p>Mammography is still the modality of choice for screening of early breast cancer, and breast cancers detected by mammography are usually smaller than those detected clinically.</p>
<p><a href="../../../m/a/g/Magnetic_resonance_imaging.html" title="Magnetic resonance imaging">Magnetic resonance imaging</a> (MRI) has been shown to detect cancers that are not visible on mammograms, but it has several disadvantages. For example, although it is 27-36% more sensitive, it is less specific than mammography.<sup id="_ref-23" class="reference"><a href="#_note-23" title="">[45]</a></sup> As a result, MRI studies will have more <a href="../../../t/y/p/Type_I_and_type_II_errors_c67e.html" title="Type I and type II errors">false positives</a> (up to 5%), which may have undesirable financial and psychological costs. It is also a relatively expensive procedure, and one which requires the intravenous injection of a chemical agent to be effective. Proposed Indications for using MRI for screening include:<sup id="_ref-24" class="reference"><a href="#_note-24" title="">[46]</a></sup></p>
<ul>
<li>Strong family history of breast cancer</li>
<li>Patients with BRCA-1 or BRCA-2 oncogene mutations</li>
<li>Evaluation of women with breast implants</li>
<li>History of previous lumpectomy or breast biopsy surgeries</li>
<li>Axillary metastasis with an unknown primary tumor</li>
<li>Very dense or scarred breast tissue</li>
</ul>
<p><a href="../../../m/e/d/Medical_ultrasonography.html" title="Medical ultrasonography">Ultrasound</a> alone is not adequate as a screening tool but it is a useful additional for the characterization of palpable tumours and directing image-guided biopsies.</p>
<p>The U.S. <a href="../../../n/a/t/National_Cancer_Institute_eeb0.html" title="National Cancer Institute">National Cancer Institute</a> recommends screening mammography with a baseline mammogram at age 35, mammograms every two years beginning at age 40, and then annual mammograms beginning at age 50. In the UK, women are invited to attend for screening once every three years beginning at age 50. Women with one or more first-degree relatives (mother, sister, daughter) with premenopausal breast cancer should begin screening at an earlier age. It is usually suggested to start screening at an age that is 10 years less than the age at which the relative was diagnosed with breast cancer. More and more men are being prompted to undertake breast screening due to the rise of breast cancer in men.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since March 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></p>
<p>Several scientific groups however have expressed concern on the perceived benefits of breast screening by the public.<sup id="_ref-25" class="reference"><a href="#_note-25" title="">[47]</a></sup> In 2001, a controversial review published in <a href="../../../t/h/e/The_Lancet_6c53.html" title="The Lancet">The Lancet</a> claimed that <i>there is no reliable evidence that screening for breast cancer reduces mortality</i>.<sup id="_ref-26" class="reference"><a href="#_note-26" title="">[48]</a></sup> The results of this study were widely reported in the popular press.<sup id="_ref-27" class="reference"><a href="#_note-27" title="">[49]</a></sup></p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<p>The diagnosis of breast cancer is established by the pathological examination of removed breast tissue. Such tissue is generally obtained at the time of surgical treatment. A number of procedures have been devised to obtain tissue or cells prior to the treatment for histological or cytological examination. Such procedures include fine-needle aspiration, nipples aspirates, ductal lavage, core needle biopsy, and local surgical <a href="../../../b/i/o/Biopsy.html" title="Biopsy">biopsy</a>. Most of these diagnostic steps, however, have some limitations as they may not yield enough tissue or miss the cancer, while the surgical biopsy already becomes an invasive procedure. Imaging tests are used to detect <a href="../../../m/e/t/Metastasis.html" title="Metastasis">metastasis</a> and include <a href="../../../c/h/e/Chest_x-ray.html" title="Chest x-ray">chest x-ray</a>, <a href="../../../b/o/n/Bone_scan.html" title="Bone scan">bone scan</a>, <a href="../../../c/a/t/Cat_scan.html" title="Cat scan">CT</a>, <a href="../../../m/r/i/MRI_7148.html" title="MRI">MRI</a>, and <a href="../../../p/o/s/Positron_emission_tomography.html" title="Positron emission tomography">PET</a> scanning. Ca 15.3 (carbohydrate antigen 15.3, epithelial mucin) is a <a href="../../../t/u/m/Tumor_marker.html" title="Tumor marker">tumor marker</a> determined in blood which can be used to follow up disease activity.</p>
<p>Breast cancer is staged. Not only will this allow for better understanding of the disease process, but it will also facilitate interpretation of data, and determine treatment. Prognosis is closely linked to results of staging.</p>
<p><b>Summary of stages:</b></p>
<ul>
<li><i>Stage 0</i> - <a href="../../../c/a/r/Carcinoma_in_situ.html" title="Carcinoma in situ">Carcinoma in situ</a></li>
<li><i>Stage I</i> - Tumor (T) does not exceed 2 cm, no axillary lymph nodes (N) involved.</li>
<li><i>Stage IIA</i> – T 2-5 cm, N negative, or T &lt;2 cm and N positive.</li>
<li><i>Stage IIB</i> – T &gt; 5 cm, N negative, or T 2-5 cm and N positive (&lt; 4 axillary nodes).</li>
<li><i>Stage IIIA</i> – T &gt; 5 cm, N positive, or T 2-5 cm with 4 or more axillary nodes</li>
<li><i>Stage IIIB</i> – T has penetrated chest wall or skin, and may have spread to &lt; 10 axillary N</li>
<li><i>Stage IIIC</i> – T has &gt; 10 axillary N, 1 or more supraclavicular or infraclavicular N, or internal mammary N.</li>
<li><i>Stage IV</i> – Distant metastasis (M)</li>
</ul>
<p>Breast lesions are examined for certain markers, notably sex steroid hormone receptors. About two thirds of postmenopausal breast cancers are <a href="../../../e/s/t/Estrogen_receptor.html" title="Estrogen receptor">estrogen receptor</a> positive (ER+) and <a href="../../../p/r/o/Progesterone_receptor.html" title="Progesterone receptor">progesterone receptor</a> positive (PR+).<sup id="_ref-28" class="reference"><a href="#_note-28" title="">[50]</a></sup> Receptor status modifies the treatment as, for instance, ER+ lesions are more sensitive to hormonal therapy.</p>
<p>The breast lesion will also be tested for the presence of human epidermal growth factor a protein also known as HER2, neu or erbB2. HER2 is a cell-surface protein involved in cell development. In normal cells, HER2 controls aspects of cell growth and division. When activated in cancer cells, HER2 accelerates tumor formation. About 20-30% of breast cancers overexpress HER2. Those patients may be candidates for the drug Herceptin.<sup id="_ref-29" class="reference"><a href="#_note-29" title="">[51]</a></sup></p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p>The mainstay of breast cancer treatment is <a href="../../../s/u/r/Surgery.html" title="Surgery">surgery</a> when the tumor is localized, with possible adjuvant hormonal therapy (with <a href="../../../t/a/m/Tamoxifen.html" title="Tamoxifen">tamoxifen</a> or an <a href="../../../a/r/o/Aromatase_inhibitor.html" title="Aromatase inhibitor">aromatase inhibitor</a>), <a href="../../../c/h/e/Chemotherapy.html" title="Chemotherapy">chemotherapy</a>, and/or <a href="../../../r/a/d/Radiotherapy.html" title="Radiotherapy">radiotherapy</a>. At present, the treatment recommendations after surgery (adjuvant therapy) follow a pattern. This pattern may be adapted as every two years a worldwide conference takes place in St. Gallen, Switzerland to discuss the actual results of worldwide multi-center studies. Depending on clinical criteria (age, type of cancer, size, metastasis) patients are roughly divided to high risk and low risk cases which follow different rules for therapy. Treatment possibilities include Radiation Therapy, Chemotherapy, Hormone Therapy, and Immune Therapy.</p>
<p>An online resource for helping to quantify the relative risks and benefits of chemotherapy v. hormonal therapy is Adjuvant! Online (see below).</p>
<p>In planning treatment, doctors can also use PCR tests like <a href="../../../o/n/c/Oncotype_DX_a5d4.html" title="Oncotype DX">Oncotype DX</a> or <a href="../../../m/i/c/Microarray.html" title="Microarray">microarray</a> tests like <a href="../../../m/a/m/MammaPrint_0ec4.html" title="MammaPrint">MammaPrint</a> that predict breast cancer recurrence risk based on gene expression. In February 2006, the MammaPrint test became the first breast cancer predictor to win formal approval from the Food and Drug Administration. This is a new gene test to help predict whether women with early stage breast cancer will relapse in five or 10 years, this could help influence how aggressively they fight the initial tumor.<sup id="_ref-NewsMax_0" class="reference"><a href="#_note-NewsMax" title="">[52]</a></sup></p>
<p>The emotional impact of cancer diagnosis, symptoms, treatment, and related issues can be severe. Most larger hospitals are associated with <a href="../../../c/a/n/Cancer_support_group.html" title="Cancer support group">cancer support groups</a> which can help patients cope with the many issues that come up in a supportive environment with other people with experience with similar issues. Online <a href="../../../c/a/n/Cancer_support_group.html" title="Cancer support group">cancer support groups</a> are also very beneficial to cancer patients, especially in dealing with uncertainty and body-image problems inherent in cancer treatment.</p>
<p><a name="Surgery" id="Surgery"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Surgery">edit</a>]</span> <span class="mw-headline">Surgery</span></h3>
<p>Depending on the staging and type of the tumor, just a <a href="../../../l/u/m/Lumpectomy.html" title="Lumpectomy">lumpectomy</a> (removal of the lump only) may be all that is necessary or removal of larger amounts of breast tissue may be necessary. Surgical removal of the entire breast is called <a href="../../../m/a/s/Mastectomy.html" title="Mastectomy">mastectomy</a>.</p>
<p>While there has been an increasing utilization of lumpectomy techniques for breast-conservation cancer surgery, mastectomy may be the preferred treatment in certain instances:</p>
<ul>
<li>Two or more tumors exist in different areas of the breast (a "multifocal" cancer).</li>
<li>The breast has previously received <a href="../../../r/a/d/Radiation.html" title="Radiation">radiation</a> (XRT) treatment.</li>
<li>The tumor is large relative to the size of the breast.</li>
<li>The patient has had <a href="../../../s/c/l/Scleroderma.html" title="Scleroderma">scleroderma</a> or another disease of the connective tissue, which can complicate XRT treatment.</li>
<li>The patient lives in an area where XRT is inaccessible.</li>
<li>The patient is apprehensive about their risk of local recurrence after lumpectomy.</li>
</ul>
<p>Standard practice requires the surgeon to establish that the tissue removed in the operation has margins clear of cancer, indicating that the cancer has been completely excised. If the tissue removed does not have clear margins, then further operations to remove more tissue may be necessary. This may sometimes require removal of part of the <a href="../../../p/e/c/Pectoralis_major_muscle.html" title="Pectoralis major muscle">pectoralis major muscle</a> which is the main muscle of the anterior chest wall.</p>
<p>During the operation, the <a href="../../../l/y/m/Lymph_nodes.html" title="Lymph nodes">lymph nodes</a> in the <a href="../../../a/x/i/Axilla.html" title="Axilla">axilla</a> are also considered for removal. In the past, large axillary operations took out ten to forty nodes to establish whether cancer had spread. This had the unfortunate side effect of frequently causing <a href="../../../l/y/m/Lymphedema.html" title="Lymphedema">lymphedema</a> of the arm on the same side, as the removal of this many lymph nodes affected lymphatic drainage. More recently, the technique of <a href="../../../s/e/n/Sentinel_lymph_node.html" title="Sentinel lymph node">sentinel lymph node</a> (SLN) dissection has become popular, as it requires the removal of far fewer lymph nodes, resulting in fewer side effects. The sentinel lymph node is the first node that drains the tumor, and subsequent SLN mapping can save 65-70% of patients with breast cancer from having a complete lymph node dissection for what could turn out to be a negative nodal basin. SLN biopsy is indicated for patients with T1 and T2 lesions (&lt;5cm) and carries a number of recommendations for use on patient subgroups.<sup id="_ref-30" class="reference"><a href="#_note-30" title="">[53]</a></sup></p>
<p><a name="Radiation_therapy" id="Radiation_therapy"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Radiation therapy">edit</a>]</span> <span class="mw-headline">Radiation therapy</span></h3>
<p>Radiation therapy consists of the use of high powered X-rays or <a href="../../../g/a/m/Gamma_ray.html" title="Gamma ray">gamma rays</a> (XRT) that precisely target the area that is being treated. These X-rays or gamma rays are very effective in destroying the cancer cells that might recur where the tumor was removed. These X-rays are delivered by a machine called a <a href="../../../l/i/n/Linear_particle_accelerator.html" title="Linear particle accelerator">linear Accelerator</a> or LINAC. Alternatively, the use of implanted radioactive catheters (brachytherapy), similar to those used in prostate cancer treatment, is being evaluated. The use of radiation therapy for breast cancer is usually given after surgery has been performed and is an essential component of breast conserving therapy. The purpose of radiation is to reduce the chance that the cancer will recur.</p>
<p>Radiation therapy works for breast cancer by eliminating the microscopic cancer cells that may remain near the area where the tumor was removed during surgery. Since by the nature of radiation and its effects on normal cells and cancer cells alike the dose that is given is to ensure that the cancer cells are eliminated. However, the dose cannot be given in one sitting. Radiation causes some damage to the normal tissue around where the tumor was but normal healthy tissue can repair itself. The treatments are given typically over a period of five to seven weeks, performed five days a week. Each treatment session takes about fifteen minutes per day. Breaking the treatments up over this extended period of time gives the healthy normal tissue a chance to repair itself. Cancer cells do not repair themselves as well as normal cells, which explains the efficacy of radiation therapy.</p>
<p>Although radiation therapy can reduce the chance that breast cancer will recur in the breast, it is much less effective in prolonging patient survival. The National Cancer Institute reviews this information.<sup id="_ref-31" class="reference"><a href="#_note-31" title="">[54]</a></sup> in a paragraph that begins:“Breast-conserving surgery alone without radiation therapy . . .” The NCI includes six studies; none of them found a survival benefit for radiation therapy. Abstracts from all six studies are available for review. Patients who are unable to have radiation therapy after lumpectomy should consult with a surgeon who understands this research and who believes that lumpectomy (or partial mastectomy) alone is a reasonable treatment option.</p>
<p><a name="Indications_for_radiation" id="Indications_for_radiation"></a></p>
<h4><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Indications for radiation">edit</a>]</span> <span class="mw-headline">Indications for radiation</span></h4>
<p>Indications for radiation treatment are constantly evolving. Patients treated in Europe have been more likely in the past to be recommended adjuvant radiation after breast cancer surgery. <a href="../../../r/a/d/Radiation_therapy.html" title="Radiation therapy">Radiation therapy</a> is usually recommended for all patients who had (lumpectomy, quadrant-resection). Radiation therapy is usually not indicated in patients with advanced (stage IV disease) except for palliation of symptoms like bone pain.</p>
<p>In general recommendations would include:</p>
<ul>
<li><b>As part of breast conserving therapy</b> of breast cancer when the whole breast is not removed (lumpectomy or wide local excision)</li>
<li><b>After mastectomy</b>: Patients with higher chances of cancer recurring such as&#160;: large primary tumor and involvement of 4 or more lymph nodes.</li>
</ul>
<p>Other factors which may influence adding adjuvant</p>
<ul>
<li>Tumor close to or to the margins on pathology specimen</li>
<li>Multiple areas of tumor (multicentric disease)</li>
<li>Microscopic invasion of lymphatic or vascular tissues</li>
<li>Microcopic invasion of the skin, nipple/areola, or underlying pectoralis major muscle</li>
<li>Patients with &lt;4 LN involved, but extension out of the substance of a LN</li>
<li>Inadequate numbers of axillary LN sampled</li>
</ul>
<p><a name="Types_of_radiotherapy" id="Types_of_radiotherapy"></a></p>
<h4><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Types of radiotherapy">edit</a>]</span> <span class="mw-headline">Types of radiotherapy</span></h4>
<p>Radiotherapy can be delivered in many ways. Most commonly this is done using radiation from linear accelerators. Since this is delivered from outside, one needs to restrict the amount of dose that can be given at one time so that normal tissues are not harmed. So the course usually lasts for several days, typically every day for 5 to 6 weeks.</p>
<p>New technology has allowed more precise delivery of radiotherapy in a portable fashion - for example in the operating theatre. Targeted intraoperative radiotherapy (TARGIT).<sup id="_ref-32" class="reference"><a href="#_note-32" title="">[55]</a></sup> is a method of delivering therapeutic radiation from within the breast using a portable x-ray generator called Intrabeam. It is undergoing clinical trials in several countries at present to test whether it can replace the whole course of radiotherapy in selected patients.<sup id="_ref-Vaidya_2000_0" class="reference"><a href="#_note-Vaidya_2000" title="">[56]</a></sup> It may also be able provide a much better boost dose to the tumour bed and appears to provide superior control.<sup id="_ref-Vaidya_2006_0" class="reference"><a href="#_note-Vaidya_2006" title="">[57]</a></sup> This will be tested in a Targit-B trial.<sup id="_ref-33" class="reference"><a href="#_note-33" title="">[58]</a></sup></p>
<p><a name="Side_effects_of_radiation_therapy" id="Side_effects_of_radiation_therapy"></a></p>
<h4><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Side effects of radiation therapy">edit</a>]</span> <span class="mw-headline">Side effects of radiation therapy</span></h4>
<p>The side effects of radiation have decreased considerably over the past decades. Aside from general fatigue caused by the healthy tissue repairing itself, there will probably be no side effects at all. Some patients develop a suntan-like change in skin color in the exact area being treated. As with a suntan, this darkening of the skin will fade with time. Other side effects experienced with radiation include the fact that radiation therapy can and often does cause permanent changes in the color and texture of skin, in addition to:</p>
<ul>
<li>reddening of the skin</li>
<li>muscle stiffness</li>
<li>mild swelling</li>
<li>tenderness in the area</li>
<li>long-term shrinking of the irradiated breast</li>
</ul>
<p>Along with improved cosmetic outcome of treatment with radiation, there have been improvements in the techniques that deliver radiation to the breast. One such new technology is using IMRT (intensity modulated radiation therapy), in which the radiation oncologist can change the shape and intensity of the radiation beam at different points across and inside the breast. This allows for a more focused beam of radiation directed at the tumor cells and leaves most of the healthy tissue unaffected by the radiation.</p>
<p>Another new procedure involves a type of <a href="../../../b/r/a/Brachytherapy.html" title="Brachytherapy">brachytherapy</a>, where a radioactive source is temporarily placed inside the breast in direct contact with the tumor bed (area where tumor was removed). This technique is called a Mammosite and is currently undergoing clinic trials.</p>
<p>The use of adjuvant radiation has significant potential effects if the patient has to later undergo <a href="../../../b/r/e/Breast_reconstruction.html" title="Breast reconstruction">breast reconstruction</a> surgery. Fibrosis of chest wall skin from radiation negatively affects skin elasticity and makes <a href="../../../t/i/s/Tissue_expansion.html" title="Tissue expansion">tissue expansion</a> techniques difficult. Traditionally most patients are advised to defer immediate breast reconstruction when adjuvant radiation is planned and are most often recommended surgery involving autologous tissue reconstruction rather then <a href="../../../b/r/e/Breast_implants.html" title="Breast implants">breast implants</a>.</p>
<p><a name="Systemic_therapy" id="Systemic_therapy"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Systemic therapy">edit</a>]</span> <span class="mw-headline">Systemic therapy</span></h3>
<p>Systemic therapy uses medications to treat cancer cells throughout the body. Any combination of systemic treatments may be used to treat breast cancer. Systemic treatments include chemotherapy, immune therapy, and hormonal therapy.</p>
<p><a name="Chemotherapy" id="Chemotherapy"></a></p>
<h4><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Chemotherapy">edit</a>]</span> <span class="mw-headline">Chemotherapy</span></h4>
<p>Chemotherapy can be given both before and after surgery. Neo-adjuvant chemotherapy is used to shrink the size of a tumor prior to surgery. Adjuvant chemotherapy is given after surgery to reduce the risk of recurrence.</p>
<p>Several different chemotherapy regimens may be used. Determining the appropriate regimen depends on many factors, including the character of the tumor, lymph node status, and the age and health of the patient. Possible chemotherapy regimens include:</p>
<ul>
<li><a href="../../../c/m/f/CMF_%28therapy%29_3bed.html" title="CMF (therapy)">CMF</a>: <a href="../../../c/y/c/Cyclophosphamide.html" title="Cyclophosphamide">cyclophosphamide</a>, <a href="../../../m/e/t/Methotrexate.html" title="Methotrexate">methotrexate</a>, and 5-<a href="../../../f/l/u/Fluorouracil.html" title="Fluorouracil">fluorouracil</a></li>
<li>FAC: 5-fluorouracil, <a href="../../../d/o/x/Doxorubicin.html" title="Doxorubicin">doxorubicin</a>, cyclophosphamide</li>
<li>AC (or CA): Adriamycin (doxorubicin) and cyclophosphamide</li>
<li>AC with <a href="../../../p/a/c/Paclitaxel.html" title="Paclitaxel">paclitaxel</a> administered after the AC</li>
<li><a href="../../../t/a/c/TAC_e7a2.html" title="TAC">TAC</a>: Taxotere (<a href="../../../d/o/c/Docetaxel.html" title="Docetaxel">docetaxel</a>), Adriamycin (doxorubicin), and cyclophosphamide</li>
<li>FEC: 5-fluorouracil, epirubucin and cyclophosphamide for 6 cycles</li>
<li>FEC for three cycles followed by docetaxel for three cycles</li>
<li>Dose dense AC: doxorubicin and cyclophosphamide followed by paclitaxel</li>
<li>TC: Taxotere (<a href="../../../d/o/c/Docetaxel.html" title="Docetaxel">docetaxel</a>) and <a href="../../../c/y/c/Cyclophosphamide.html" title="Cyclophosphamide">cyclophosphamide</a></li>
</ul>
<p>Since chemotherapy affects the production of white blood cells, a growth factor, e.g. <a href="../../../p/e/g/Pegfilgrastim.html" title="Pegfilgrastim">pegfilgrastim</a>, is sometimes administered along with chemotherapy. This has been shown to reduce, though not completely prevent, the rate of infection and low white cell count.</p>
<p>Chemotherapy has increasing side effects as the patient's age passes 65.</p>
<p><a name="Hormonal_treatment" id="Hormonal_treatment"></a></p>
<h4><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Hormonal treatment">edit</a>]</span> <span class="mw-headline">Hormonal treatment</span></h4>
<p>Patients with estrogen receptor positive tumors will typically receive a hormonal treatment after chemotherapy is completed. Typical hormonal treatments include:</p>
<ul>
<li><a href="../../../t/a/m/Tamoxifen.html" title="Tamoxifen">Tamoxifen</a> is typically given to premenopausal women to inhibit the estrogen receptors</li>
<li><a href="../../../a/r/o/Aromatase_inhibitors.html" title="Aromatase inhibitors">Aromatase inhibitors</a> are typically given to postmenopausal women to lower the amount of estrogen in their systems</li>
<li>GnRH-analogues</li>
<li>ovarian ablation or suppression is used in premenopausal women</li>
</ul>
<p>However, a recent statistic data shows breast cancer rate dropped dramatically in 2003 and the declining use of hormone could be the reason <a href="http://abcnews.go.com/Health/wireStory?id=2726459&amp;CMP=OTC-RSSFeeds0312" class="external autonumber" title="http://abcnews.go.com/Health/wireStory?id=2726459&amp;CMP=OTC-RSSFeeds0312" rel="nofollow">[2]</a>.</p>
<p><a name="Targeted_therapy" id="Targeted_therapy"></a></p>
<h4><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Targeted therapy">edit</a>]</span> <span class="mw-headline">Targeted therapy</span></h4>
<p>In patients whose cancer expresses an over-abundance of the HER2 protein the drug <a href="../../../t/r/a/Trastuzumab.html" title="Trastuzumab">trastuzumab</a> (Herceptin ®) is used to block the HER2 protein in breast cancer cells slowing their growth. This drug was originally used only in the treatment of patients with metastatic disease, however in the summer of 2005 two large clinical trials published results suggesting that patients with early-stage disease also benefit significantly from Herceptin.</p>
<p><a name="Preclinical" id="Preclinical"></a></p>
<h4><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Preclinical">edit</a>]</span> <span class="mw-headline">Preclinical</span></h4>
<p><a name="Flax_seeds" id="Flax_seeds"></a></p>
<h5><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Flax seeds">edit</a>]</span> <span class="mw-headline">Flax seeds</span></h5>
<p>Preliminary research into flax seeds indicate that flax can significantly inhibit breast cancer growth and metastasis, and enhance the inhibitory effect of tamoxifen on estrogen-dependent tumors.<sup id="_ref-34" class="reference"><a href="#_note-34" title="">[59]</a></sup><sup id="_ref-35" class="reference"><a href="#_note-35" title="">[60]</a></sup><sup id="_ref-36" class="reference"><a href="#_note-36" title="">[61]</a></sup><sup id="_ref-37" class="reference"><a href="#_note-37" title="">[62]</a></sup></p>
<p><a name="Alternative_medicine" id="Alternative_medicine"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Alternative medicine">edit</a>]</span> <span class="mw-headline">Alternative medicine</span></h3>
<p>The use of <a href="../../../t/r/a/Traditional_Chinese_medicine_294b.html" title="Traditional Chinese medicine">traditional Chinese medicine</a> to treat breast cancer has been claimed, but no successful clinical trials have yet been reported.</p>
<p><a name="Prognosis" id="Prognosis"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Prognosis">edit</a>]</span> <span class="mw-headline">Prognosis</span></h2>
<p>There are several prognostic factors associated with breast cancer. <a href="../../../c/a/n/Cancer_staging.html" title="Cancer staging">Stage</a> is the single most important prognostic factor in breast cancer, as it will take into consideration local involvement, lymph node status and whether metastatic disease is present or not. The higher the stage at the time of diagnosis, the worse the prognosis of breast cancer is. Node negative breast cancer patients have a much better prognosis compared to node positive patients.</p>
<p>Presence of estrogen and progesterone receptors in the cancer cell is another important prognostic factor, and may guide treatment. Hormone receptor positive breast cancer is usually associated with much better prognosis compared to hormone negative breast cancer.</p>
<p><a href="../../../h/e/r/HER2_neu_5d69.html" title="HER2/neu">HER2/neu</a> status has also been described as a prognostic factor. Patients whose cancer cells are positive for HER2/neu have more aggressive disease and may be treated with <a href="../../../t/r/a/Trastuzumab.html" title="Trastuzumab">trastuzumab</a>, a <a href="../../../m/o/n/Monoclonal_antibody.html" title="Monoclonal antibody">monoclonal antibody</a> that targets this protein.</p>
<p><a href="../../../a/s/h/Ashkenazi.html" title="Ashkenazi">Ashkenazi</a> Jewish women and black women tend to have higher rates of fatalities.</p>
<p><a name="Breast_cancer_in_males" id="Breast_cancer_in_males"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Breast cancer in males">edit</a>]</span> <span class="mw-headline">Breast cancer in males</span></h2>
<p>Less than 1% of breast cancers occur in men and incidence is about 1 in 100,000. Men with <a href="../../../g/y/n/Gynaecomastia.html" title="Gynaecomastia">gynaecomastia</a> do not have a higher risk of developing breast cancer.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since March 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup> There may be an increased incidence of breast cancer in men with <a href="../../../p/r/o/Prostate_cancer.html" title="Prostate cancer">prostate cancer</a>. The prognosis, even in stage I cases, is worse in men than in women.<sup id="_ref-AMN_0" class="reference"><a href="#_note-AMN" title="">[63]</a></sup> The treatment of men with breast cancer is similar to that in older women. Since the male breast tissue is confined to the area directly behind the nipple, treatment for males has usually been a <a href="../../../m/a/s/Mastectomy.html" title="Mastectomy">mastectomy</a> with axillary surgery. This may be followed by adjuvant radiotherapy, hormone therapy (such as tamoxifen), or chemotherapy.</p>
<p><a name="Breast_cancer_metastasis" id="Breast_cancer_metastasis"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Breast cancer metastasis">edit</a>]</span> <span class="mw-headline">Breast cancer metastasis</span></h2>
<p>Most people understand breast cancer as something that happens in the breast. However it can <a href="../../../m/e/t/Metastasis.html" title="Metastasis">metastasise</a> (spread) via lymphatics to nearby lymph nodes usually those under the arm. That is why surgery for breast cancer always involves some type of surgery for the glands under the arm- either axillary clearance, sampling or sentinel node biopsy.</p>
<p>Breast cancer can also spread to other parts of the body via blood vessels. So it can spread to the lungs, pleura (the lining of the lungs), the liver, the brain and most commonly to the bones.</p>
<p>Seventy percent of the time that breast cancer spreads to other locations, it spreads to bone, especially the vertebrae and the long bones of the arms, legs and ribs. Breast cancer cells "set up housekeeping" in the bones and form tumors. When breast cancer is found in bones, it has usually spread to more than one site. At this stage, it is treatable, often for many years, but it is not curable.</p>
<p>Like normal breast cells, these tumors in the bone often thrive on female hormones, especially estrogen. Therefore, the doctor often treats the patient with medicines that lower her estrogen levels.</p>
<p>Usually when breast cancer spreads to bone, it eats away healthy bone causing weak spots. The bones break easily at these weak spots. That is why breast cancer patients are often seen wearing braces or using a wheel chair, and why they complain about aching bones. If a patient has had breast cancer in the past and notices pain in the bones, the patient should see a doctor.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></p>
<p><a name="Breast_cancer_awareness" id="Breast_cancer_awareness"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Breast cancer awareness">edit</a>]</span> <span class="mw-headline">Breast cancer awareness</span></h2>
<div class="floatright"><span><a href="../../../p/i/n/Image%7EPink_ribbon.svg_7357.html" class="image" title="Pink ribbon"><img src="../../../upload/shared/thumb/b/b5/Pink_ribbon.svg/40px-Pink_ribbon.svg.png" alt="Pink ribbon" width="40" height="65" longdesc="../../../p/i/n/Image%7EPink_ribbon.svg_7357.html" /></a></span></div>
<p>In the month of October, breast cancer is recognized by survivors, family and friends of survivors and/or victims of the disease. A <a href="../../../p/i/n/Pink_ribbon.html" title="Pink ribbon">pink ribbon</a> is worn to recognize the struggle that sufferers face when battling the cancer.</p>
<p><a href="../../../p/i/n/Pink_for_October_5a82.html" title="Pink for October">Pink for October</a> is an initiative started by Matthew Oliphant, which asks that any sites willing to help make people aware of breast cancer, change their template or layout to include the color pink, so that when visitors view the site, they see that the majority of the site is pink. Then after reading a short amount of information about breast cancer, or being redirected to another site, they are aware of the disease itself.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../l/i/s/List_of_notable_breast_cancer_patients_according_to_occupation.html" title="List of notable breast cancer patients according to occupation">List of notable breast cancer patients according to occupation</a></li>
<li><a href="../../../l/i/s/List_of_notable_breast_cancer_patients_according_to_survival_status.html" title="List of notable breast cancer patients according to survival status">List of notable breast cancer patients according to survival status</a></li>
<li><a href="../../../l/i/s/List_of_breast_carcinogenic_substances.html" title="List of breast carcinogenic substances">List of breast carcinogenic substances</a></li>
<li><a href="../../../m/a/m/Mammary_tumor.html" title="Mammary tumor">Mammary tumor</a> for breast cancer in other animals</li>
<li><a href="../../../b/r/e/Breast_reconstruction.html" title="Breast reconstruction">Breast reconstruction</a></li>
<li><a href="../../../a/l/c/Alcohol_and_cancer.html" title="Alcohol and cancer">Alcohol and cancer</a></li>
<li><a href="../../../m/a/m/Mammography_Quality_Standards_Act_5262.html" title="Mammography Quality Standards Act">Mammography Quality Standards Act</a></li>
<li><a href="../../../n/a/t/National_Breast_Cancer_Coalition_39a0.html" title="National Breast Cancer Coalition">National Breast Cancer Coalition</a></li>
<li><a href="../../../b/r/e/Breast_Cancer_Action_bbe6.html" title="Breast Cancer Action">Breast Cancer Action</a></li>
<li><a href="../../../b/a/r/Barron_Lerner_52bf.html" title="Barron Lerner">Barron Lerner</a> (Physician)</li>
<li><a href="../../../w/i/l/William_Stewart_Halsted_f729.html" title="William Stewart Halsted">William Stewart Halsted</a> (Radical Masectomy)</li>
<li><a href="http://foundation.nsabp.org/" class="external text" title="http://foundation.nsabp.org/" rel="nofollow">NSABP- Breast Cancer Research Clinical Trials Group</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small" style="-moz-column-count:2; column-count:2};">
<ol class="references">
<li id="_note-indy">^ <a href="#_ref-indy_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-indy_1" title=""><sup><i><b>b</b></i></sup></a> Laurance, Jeremy. "<a href="http://news.independent.co.uk/uk/health_medical/article1771835.ece" class="external text" title="http://news.independent.co.uk/uk/health_medical/article1771835.ece" rel="nofollow">Breast cancer cases rise 80% since Seventies</a>", <i><a href="../../../t/h/e/The_Independent_de8a.html" title="The Independent">The Independent</a></i>, 2006-09-29. Retrieved on <a href="../../../o/c/t/October_9.html" title="October 9">October 9</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>.</li>
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <a href="http://imaginis.com/breasthealth/statistics.asp" class="external text" title="http://imaginis.com/breasthealth/statistics.asp" rel="nofollow">Breast Cancer: Statistics on Incidence, Survival, and Screening</a>. <i><a href="http://imaginis.com" class="external text" title="http://imaginis.com" rel="nofollow">Imaginis Corporation</a></i> (2006). Retrieved on <a href="../../../o/c/t/October_9.html" title="October 9">October 9</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>.</li>
<li id="_note-Dave"><b><a href="#_ref-Dave_0" title="">^</a></b> <a href="http://www.cancer.gov/cancertopics/pdq/treatment/malebreast/healthprofessional" class="external text" title="http://www.cancer.gov/cancertopics/pdq/treatment/malebreast/healthprofessional" rel="nofollow">Male Breast Cancer Treatment - National Cancer Institute</a>. <i><a href="http://www.cancer.gov/" class="external text" title="http://www.cancer.gov/" rel="nofollow">National Cancer Institute</a></i> (2006). Retrieved on <a href="../../../o/c/t/October_16.html" title="October 16">October 16</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>.</li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <a href="http://www.cancer.org/docroot/CRI/content/CRI_2_6x_the_history_of_cancer_72.asp?sitearea=CRI" class="external text" title="http://www.cancer.org/docroot/CRI/content/CRI_2_6x_the_history_of_cancer_72.asp?sitearea=CRI" rel="nofollow">The History of Cancer</a>. <i><a href="../../../a/m/e/American_Cancer_Society_165c.html" title="American Cancer Society">American Cancer Society</a></i> (2002-03-25). Retrieved on <a href="../../../o/c/t/October_9.html" title="October 9">October 9</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>.</li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <cite style="font-style:normal">Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, et al.. "Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study (WINS).". <i>J Natl Cancer Inst</i> <b>98</b> (24): 1767-1776. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17179478" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17179478">PMID 17179478</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Dietary+fat+reduction+and+breast+cancer+outcome%3A+interim+efficacy+results+from+the+Women%27s+Intervention+Nutrition+Study+%28WINS%29.&amp;rft.title=J+Natl+Cancer+Inst&amp;rft.jtitle=J+Natl+Cancer+Inst&amp;rft.volume=98&amp;rft.issue=24&amp;rft.au=Chlebowski+RT%2C+Blackburn+GL%2C+Thomson+CA%2C+Nixon+DW%2C+Shapiro+A%2C+Hoy+MK%2C+et+al.&amp;rft.pages=1767-1776&amp;rft_id=info:pmid/17179478">&#160;</span></li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> <a href="http://www.breastcancer.org/cmn_who_indrisk.html" class="external text" title="http://www.breastcancer.org/cmn_who_indrisk.html" rel="nofollow">Individual Risk Factors</a>. BreastCander.org. Retrieved on <a href="../../../m/a/r/March_11.html" title="March 11">March 11</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-Albright"><b><a href="#_ref-Albright_0" title="">^</a></b> Albright M (2002-10-01). <a href="http://zmagsite.zmag.org/oct2002/commentary/albright1002.htm" class="external text" title="http://zmagsite.zmag.org/oct2002/commentary/albright1002.htm" rel="nofollow">Marketing Fear</a>. <i>Zmagsite</i>. Retrieved on <a href="../../../m/a/r/March_11.html" title="March 11">March 11</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-UKDOH_Alcohol"><b><a href="#_ref-UKDOH_Alcohol_0" title="">^</a></b> <a href="http://www.advisorybodies.doh.gov.uk/pdfs/alcbrrev.pdf" class="external text" title="http://www.advisorybodies.doh.gov.uk/pdfs/alcbrrev.pdf" rel="nofollow">Review of Alcohol: Association with Breast Cancer</a>. U.K. Dept. of Health. Retrieved on <a href="../../../m/a/r/March_11.html" title="March 11">March 11</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-Friedenreich_1993"><b><a href="#_ref-Friedenreich_1993_0" title="">^</a></b> <cite style="font-style:normal">Friedenreich C, Howe G, Miller A, Jain M (1993). "A cohort study of alcohol consumption and risk of breast cancer". <i>Am J Epidemiol</i> <b>137</b> (5): 512-20. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8465803" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8465803">PMID 8465803</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+cohort+study+of+alcohol+consumption+and+risk+of+breast+cancer&amp;rft.title=Am+J+Epidemiol&amp;rft.jtitle=Am+J+Epidemiol&amp;rft.date=1993&amp;rft.volume=137&amp;rft.issue=5&amp;rft.au=Friedenreich+C%2C+Howe+G%2C+Miller+A%2C+Jain+M&amp;rft.pages=512-20&amp;rft_id=info:pmid/8465803">&#160;</span></li>
<li id="_note-Longnecker_1988"><b><a href="#_ref-Longnecker_1988_0" title="">^</a></b> <cite style="font-style:normal">Longnecker M, Berlin J, Orza M, Chalmers T (1988). "A meta-analysis of alcohol consumption in relation to risk of breast cancer". <i>JAMA</i> <b>260</b> (5): 652-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3392790" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3392790">PMID 3392790</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+meta-analysis+of+alcohol+consumption+in+relation+to+risk+of+breast+cancer&amp;rft.title=JAMA&amp;rft.jtitle=JAMA&amp;rft.date=1988&amp;rft.volume=260&amp;rft.issue=5&amp;rft.au=Longnecker+M%2C+Berlin+J%2C+Orza+M%2C+Chalmers+T&amp;rft.pages=652-6&amp;rft_id=info:pmid/3392790">&#160;</span></li>
<li id="_note-Longnecker_1992"><b><a href="#_ref-Longnecker_1992_0" title="">^</a></b> <cite style="font-style:normal">Longnecker MP (1992). "Alcohol consumption in relation to risk of cancers of the breast and large bowel". <i>Alcohol Health &amp; Research World</i> <b>16</b> (3): 223-229.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alcohol+consumption+in+relation+to+risk+of+cancers+of+the+breast+and+large+bowel&amp;rft.title=Alcohol+Health+%26+Research+World&amp;rft.jtitle=Alcohol+Health+%26+Research+World&amp;rft.date=1992&amp;rft.volume=16&amp;rft.issue=3&amp;rft.au=Longnecker+MP&amp;rft.pages=223-229">&#160;</span></li>
<li id="_note-Nasca_1990"><b><a href="#_ref-Nasca_1990_0" title="">^</a></b> <cite style="font-style:normal">Nasca P, Baptiste M, Field N, Metzger B, Black M, Kwon C, Jacobson H (1990). "An epidemiological case-control study of breast cancer and alcohol consumption". <i>Int J Epidemiol</i> <b>19</b> (3): 532-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2262245" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2262245">PMID 2262245</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=An+epidemiological+case-control+study+of+breast+cancer+and+alcohol+consumption&amp;rft.title=Int+J+Epidemiol&amp;rft.jtitle=Int+J+Epidemiol&amp;rft.date=1990&amp;rft.volume=19&amp;rft.issue=3&amp;rft.au=Nasca+P%2C+Baptiste+M%2C+Field+N%2C+Metzger+B%2C+Black+M%2C+Kwon+C%2C+Jacobson+H&amp;rft.pages=532-8&amp;rft_id=info:pmid/2262245">&#160;</span></li>
<li id="_note-Chu_1989"><b><a href="#_ref-Chu_1989_0" title="">^</a></b> <cite style="font-style:normal">Chu S, Lee N, Wingo P, Webster L (1989). "Alcohol consumption and the risk of breast cancer". <i>Am J Epidemiol</i> <b>130</b> (5): 867-77. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2683749" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2683749">PMID 2683749</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alcohol+consumption+and+the+risk+of+breast+cancer&amp;rft.title=Am+J+Epidemiol&amp;rft.jtitle=Am+J+Epidemiol&amp;rft.date=1989&amp;rft.volume=130&amp;rft.issue=5&amp;rft.au=Chu+S%2C+Lee+N%2C+Wingo+P%2C+Webster+L&amp;rft.pages=867-77&amp;rft_id=info:pmid/2683749">&#160;</span></li>
<li id="_note-Schatzkin_1989"><b><a href="#_ref-Schatzkin_1989_0" title="">^</a></b> <cite style="font-style:normal">Schatzkin A, Piantadosi S, Miccozzi M, Bartee D (1989). "Alcohol consumption and breast cancer: a cross-national correlation study". <i>Int J Epidemiol</i> <b>18</b> (1): 28-31. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2722377" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2722377">PMID 2722377</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alcohol+consumption+and+breast+cancer%3A+a+cross-national+correlation+study&amp;rft.title=Int+J+Epidemiol&amp;rft.jtitle=Int+J+Epidemiol&amp;rft.date=1989&amp;rft.volume=18&amp;rft.issue=1&amp;rft.au=Schatzkin+A%2C+Piantadosi+S%2C+Miccozzi+M%2C+Bartee+D&amp;rft.pages=28-31&amp;rft_id=info:pmid/2722377">&#160;</span></li>
<li id="_note-Webster_1983"><b><a href="#_ref-Webster_1983_0" title="">^</a></b> <cite style="font-style:normal">Webster L, Layde P, Wingo P, Ory H (1983). "Alcohol consumption and risk of breast cancer". <i>Lancet</i> <b>2</b> (8352): 724-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6136850" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6136850">PMID 6136850</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alcohol+consumption+and+risk+of+breast+cancer&amp;rft.title=Lancet&amp;rft.jtitle=Lancet&amp;rft.date=1983&amp;rft.volume=2&amp;rft.issue=8352&amp;rft.au=Webster+L%2C+Layde+P%2C+Wingo+P%2C+Ory+H&amp;rft.pages=724-6&amp;rft_id=info:pmid/6136850">&#160;</span></li>
<li id="_note-UKDOH_Chemicals"><b><a href="#_ref-UKDOH_Chemicals_0" title="">^</a></b> <a href="http://www.advisorybodies.doh.gov.uk/pdfs/alco04nontech.pdf" class="external text" title="http://www.advisorybodies.doh.gov.uk/pdfs/alco04nontech.pdf" rel="nofollow">CONSUMPTION OF ALCOHOLIC BEVERAGES AND RISK OF BREAST CANCER IN WOMEN</a>. U.K. Dept. of Health. Retrieved on <a href="../../../m/a/r/March_11.html" title="March 11">March 11</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-Petri_2004"><b><a href="#_ref-Petri_2004_0" title="">^</a></b> <cite style="font-style:normal">Petri A, Tjønneland A, Gamborg M, Johansen D, Høidrup S, Sørensen T, Grønbaek M (2004). "Alcohol intake, type of beverage, and risk of breast cancer in pre- and postmenopausal women". <i>Alcohol Clin Exp Res</i> <b>28</b> (7): 1084-90. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15252295" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15252295">PMID 15252295</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alcohol+intake%2C+type+of+beverage%2C+and+risk+of+breast+cancer+in+pre-+and+postmenopausal+women&amp;rft.title=Alcohol+Clin+Exp+Res&amp;rft.jtitle=Alcohol+Clin+Exp+Res&amp;rft.date=2004&amp;rft.volume=28&amp;rft.issue=7&amp;rft.au=Petri+A%2C+Tj%C3%B8nneland+A%2C+Gamborg+M%2C+Johansen+D%2C+H%C3%B8idrup+S%2C+S%C3%B8rensen+T%2C+Gr%C3%B8nbaek+M&amp;rft.pages=1084-90&amp;rft_id=info:pmid/15252295">&#160;</span></li>
<li id="_note-ACS_2007"><b><a href="#_ref-ACS_2007_0" title="">^</a></b> <a href="http://www.cancer.org/docroot/stt/stt_0.asp" class="external text" title="http://www.cancer.org/docroot/stt/stt_0.asp" rel="nofollow">Statistics for 2007</a>. American Cancer Society. Retrieved on <a href="../../../m/a/r/March_11.html" title="March 11">March 11</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-Boffetta_2006"><b><a href="#_ref-Boffetta_2006_0" title="">^</a></b> <cite style="font-style:normal">Boffetta, Paolo; Hashibe, Mia; La Vecchia, Carlo; Zatonski, Witold; Rehm, Jürgen (2006-03-23). "<a href="http://www3.interscience.wiley.com/cgi-bin/abstract/112550783/ABSTRACT" class="external text" title="http://www3.interscience.wiley.com/cgi-bin/abstract/112550783/ABSTRACT" rel="nofollow">The burden of cancer attributable to alcohol drinking</a>". <i>International Journal of Cancer</i> <b>119</b> (4): 884–887. <a href="../../../d/i/g/Digital_object_identifier.html" title="Digital object identifier">DOI</a>:<a href="http://dx.doi.org/10.1002/ijc.21903" class="external text" title="http://dx.doi.org/10.1002/ijc.21903" rel="nofollow">10.1002/ijc.21903</a>. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16557583" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16557583">PMID 16557583</a>. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../o/c/t/October_9.html" title="October 9">10-09</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+burden+of+cancer+attributable+to+alcohol+drinking&amp;rft.title=International+Journal+of+Cancer&amp;rft.jtitle=International+Journal+of+Cancer&amp;rft.date=2006-03-23&amp;rft.volume=119&amp;rft.issue=4&amp;rft.aulast=Boffetta&amp;rft.aufirst=Paolo&amp;rft.pages=884%E2%80%93887&amp;rft_id=info:pmid/16557583&amp;rft_id=info:doi/10.1002%2Fijc.21903&amp;rft_id=http%3A%2F%2Fwww3.interscience.wiley.com%2Fcgi-bin%2Fabstract%2F112550783%2FABSTRACT">&#160;</span></li>
<li id="_note-Maggiolini_2005"><b><a href="#_ref-Maggiolini_2005_0" title="">^</a></b> <cite style="font-style:normal">Maggiolini M, Recchia A, Bonofiglio D, Catalano S, Vivacqua A, Carpino A, Rago V, Rossi R, Andò S (2005). "The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells". <i>J Mol Endocrinol</i> <b>35</b> (2): 269-81. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16216908" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16216908">PMID 16216908</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+red+wine+phenolics+piceatannol+and+myricetin+act+as+agonists+for+estrogen+receptor+alpha+in+human+breast+cancer+cells&amp;rft.title=J+Mol+Endocrinol&amp;rft.jtitle=J+Mol+Endocrinol&amp;rft.date=2005&amp;rft.volume=35&amp;rft.issue=2&amp;rft.au=Maggiolini+M%2C+Recchia+A%2C+Bonofiglio+D%2C+Catalano+S%2C+Vivacqua+A%2C+Carpino+A%2C+Rago+V%2C+Rossi+R%2C+And%C3%B2+S&amp;rft.pages=269-81&amp;rft_id=info:pmid/16216908">&#160;</span></li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> Mayo Clinic news release <a href="../../../j/u/n/June_26.html" title="June 26">June 26</a> 2001 <a href="http://www.mayoclinic.org/news2001-rst/857.html" class="external text" title="http://www.mayoclinic.org/news2001-rst/857.html" rel="nofollow">"Folate Intake Counteracts Breast Cancer Risk Associated with Alcohol Consumption"</a></li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> Boston University <a href="http://www.bu.edu/act/alcoholandhealth/issues/issue_may04/html/04-0506-ellison_baily.html" class="external text" title="http://www.bu.edu/act/alcoholandhealth/issues/issue_may04/html/04-0506-ellison_baily.html" rel="nofollow"><i>Folate, Alcohol, and Cancer Risk</i></a></li>
<li id="_note-Zhang_1999"><b><a href="#_ref-Zhang_1999_0" title="">^</a></b> <cite style="font-style:normal">Zhang S, Hunter D, Hankinson S, Giovannucci E, Rosner B, Colditz G, Speizer F, Willett W (1999). "A prospective study of folate intake and the risk of breast cancer". <i>JAMA</i> <b>281</b> (17): 1632-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10235158" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10235158">PMID 10235158</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+prospective+study+of+folate+intake+and+the+risk+of+breast+cancer&amp;rft.title=JAMA&amp;rft.jtitle=JAMA&amp;rft.date=1999&amp;rft.volume=281&amp;rft.issue=17&amp;rft.au=Zhang+S%2C+Hunter+D%2C+Hankinson+S%2C+Giovannucci+E%2C+Rosner+B%2C+Colditz+G%2C+Speizer+F%2C+Willett+W&amp;rft.pages=1632-7&amp;rft_id=info:pmid/10235158">&#160;</span></li>
<li id="_note-6"><b><a href="#_ref-6" title="">^</a></b> <a href="http://www.cancer.org/downloads/STT/CAFF2005BrF.pdf" class="external text" title="http://www.cancer.org/downloads/STT/CAFF2005BrF.pdf" rel="nofollow">American Cancer Society (2005). Cancer Facts and Figures 2005.</a></li>
<li id="_note-7"><b><a href="#_ref-7" title="">^</a></b> <a href="http://jncicancerspectrum.oxfordjournals.org/cgi/content/abstract/jnci;87/22/1681" class="external text" title="http://jncicancerspectrum.oxfordjournals.org/cgi/content/abstract/jnci;87/22/1681" rel="nofollow">Madigan MP, Zielgler RG, Benichou J, Bryne C, Hoover RN (1995). Proportion of breast cancer cases in the United States explained by well-established risk factors. Journal of the National Cancer Institute 87: 1681-85.</a></li>
<li id="_note-8"><b><a href="#_ref-8" title="">^</a></b> Ctv.Ca News Staff. "<a href="http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20061012/breastcancer_farming_061012/20061012?hub=Health" class="external text" title="http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20061012/breastcancer_farming_061012/20061012?hub=Health" rel="nofollow">Breast cancer more likely in farm workers: study</a>", <i>Ctv.Ca</i>, 2006-10-12. Retrieved on <a href="../../../m/a/r/March_11.html" title="March 11">March 11</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-9"><b><a href="#_ref-9" title="">^</a></b> <cite style="font-style:normal">Yager JD; Davidson NE (2006). "Estrogen carcinogenesis in breast cancer". <i>New Engl J Med</i> <b>354</b> (3): 270-82. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16421368" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16421368">PMID 16421368</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Estrogen+carcinogenesis+in+breast+cancer&amp;rft.title=New+Engl+J+Med&amp;rft.jtitle=New+Engl+J+Med&amp;rft.date=2006&amp;rft.volume=354&amp;rft.issue=3&amp;rft.au=Yager+JD&amp;rft.pages=270-82">&#160;</span></li>
<li id="_note-10"><b><a href="#_ref-10" title="">^</a></b> American Cancer Society. (<a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../o/c/t/October_3.html" title="October 3">10-03</a>). <a href="http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_breast_cancer_5.asp" class="external text" title="http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_breast_cancer_5.asp" rel="nofollow">What Are the Risk Factors for Breast Cancer?</a> Retrieved <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../m/a/r/March_30.html" title="March 30">03-30</a>.</li>
<li id="_note-oxford_1996a"><b><a href="#_ref-oxford_1996a_0" title="">^</a></b> <cite style="font-style:normal">Collaborative Group on Hormonal Factors in Breast Cancer (1996). "Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies". <i><a href="../../../t/h/e/The_Lancet_6c53.html" title="The Lancet">Lancet</a></i> <b>347</b> (9017): 1713-27. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8656904" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8656904">PMID 8656904</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Breast+cancer+and+hormonal+contraceptives%3A+collaborative+reanalysis+of+individual+data+on+53%2C297+women+with+breast+cancer+and+100%2C239+women+without+breast+cancer+from+54+epidemiological+studies&amp;rft.title=%5B%5BThe+Lancet%7CLancet%5D%5D&amp;rft.jtitle=%5B%5BThe+Lancet%7CLancet%5D%5D&amp;rft.date=1996&amp;rft.volume=347&amp;rft.issue=9017&amp;rft.au=Collaborative+Group+on+Hormonal+Factors+in+Breast+Cancer&amp;rft.pages=1713-27">&#160;</span></li>
<li id="_note-oxford_1996b"><b><a href="#_ref-oxford_1996b_0" title="">^</a></b> <cite style="font-style:normal">Collaborative Group on Hormonal Factors in Breast Cancer (1996). "Breast cancer and hormonal contraceptives: further results". <i>Contraception</i> <b>54</b> (3 Suppl): 1S-106S. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8899264" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8899264">PMID 8899264</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Breast+cancer+and+hormonal+contraceptives%3A+further+results&amp;rft.title=Contraception&amp;rft.jtitle=Contraception&amp;rft.date=1996&amp;rft.volume=54&amp;rft.issue=3+Suppl&amp;rft.au=Collaborative+Group+on+Hormonal+Factors+in+Breast+Cancer&amp;rft.pages=1S-106S">&#160;</span></li>
<li id="_note-hormone">^ <a href="#_ref-hormone_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-hormone_1" title=""><sup><i><b>b</b></i></sup></a> National Cancer Institute (2006-08-03). <a href="http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/healthprofessional#Section_340" class="external text" title="http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/healthprofessional#Section_340" rel="nofollow">Hormone Therapy</a>. <i>Genetics of Breast and Ovarian Cancer</i>. Retrieved on <a href="../../../a/u/g/August_12.html" title="August 12">August 12</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>.</li>
<li id="_note-11"><b><a href="#_ref-11" title="">^</a></b> <i>The Independent</i> <a href="http://news.independent.co.uk/uk/health_medical/article1090208.ece" class="external text" title="http://news.independent.co.uk/uk/health_medical/article1090208.ece" rel="nofollow">Avoid breast cancer. Sleep in the dark...</a></li>
<li id="_note-12"><b><a href="#_ref-12" title="">^</a></b> BBC report <a href="http://news.bbc.co.uk/1/hi/health/5171838.stm" class="external text" title="http://news.bbc.co.uk/1/hi/health/5171838.stm" rel="nofollow">Weight link to breast cancer risk</a></li>
<li id="_note-13"><b><a href="#_ref-13" title="">^</a></b> American Cancer Society (<a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../o/c/t/October_3.html" title="October 3">10-03</a>). <a href="http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_breast_cancer_5.asp" class="external text" title="http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_breast_cancer_5.asp" rel="nofollow">What Are the Risk Factors for Breast Cancer?</a> Retrieved <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../m/a/r/March_30.html" title="March 30">03-30</a>.</li>
<li id="_note-14"><b><a href="#_ref-14" title="">^</a></b> Gikas PD, Mokbel K. (2005) <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16526415&amp;query_hl=5&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16526415&amp;query_hl=5&amp;itool=pubmed_docsum" rel="nofollow">Phytoestrogens and the risk of breast cancer: a review of the literature</a>. Int J Fertil Women's Med.</li>
<li id="_note-15"><b><a href="#_ref-15" title="">^</a></b> Harding, Anne. (2006) <a href="http://www.cancerpage.com/news/article.asp?id=9466" class="external text" title="http://www.cancerpage.com/news/article.asp?id=9466" rel="nofollow">Aluminum Salts Could Increase Breast Cancer Risk</a>. Reuters Health.</li>
<li id="_note-16"><b><a href="#_ref-16" title="">^</a></b> <cite style="font-style:normal">Darbre, PD (2006). "Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast.". <i>Journal of Applied Toxicology</i> <b>26</b> (3): 191-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16489580" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16489580">PMID 16489580</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Metalloestrogens%3A+an+emerging+class+of+inorganic+xenoestrogens+with+potential+to+add+to+the+oestrogenic+burden+of+the+human+breast.&amp;rft.title=Journal+of+Applied+Toxicology&amp;rft.jtitle=Journal+of+Applied+Toxicology&amp;rft.date=2006&amp;rft.volume=26&amp;rft.issue=3&amp;rft.aulast=Darbre&amp;rft.aufirst=PD&amp;rft.pages=191-7&amp;rft_id=info:pmid/16489580">&#160;</span></li>
<li id="_note-17"><b><a href="#_ref-17" title="">^</a></b> <cite style="font-style:normal">Darbre, PD (2005). "Aluminium, antiperspirants and breast cancer.". <i>Journal of Inorganic Biochemistry</i> <b>99</b> (9): 1912-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16045991" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16045991">PMID 16045991</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Aluminium%2C+antiperspirants+and+breast+cancer.&amp;rft.title=Journal+of+Inorganic+Biochemistry&amp;rft.jtitle=Journal+of+Inorganic+Biochemistry&amp;rft.date=2005&amp;rft.volume=99&amp;rft.issue=9&amp;rft.aulast=Darbre&amp;rft.aufirst=PD&amp;rft.pages=1912-9&amp;rft_id=info:pmid/16045991">&#160;</span></li>
<li id="_note-Kauff_2002"><b><a href="#_ref-Kauff_2002_0" title="">^</a></b> <cite style="font-style:normal">Kauff N, Satagopan J, Robson M, Scheuer L, Hensley M, Hudis C, Ellis N, Boyd J, Borgen P, Barakat R, Norton L, Castiel M, Nafa K, Offit K (2002). "<a href="http://content.nejm.org/cgi/content/abstract/NEJMoa020119v1" class="external text" title="http://content.nejm.org/cgi/content/abstract/NEJMoa020119v1" rel="nofollow">Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation</a>". <i>N Engl J Med</i> <b>346</b> (21): 1609-15. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12023992" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12023992">PMID 12023992</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Risk-reducing+salpingo-oophorectomy+in+women+with+a+BRCA1+or+BRCA2+mutation&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2002&amp;rft.volume=346&amp;rft.issue=21&amp;rft.au=Kauff+N%2C+Satagopan+J%2C+Robson+M%2C+Scheuer+L%2C+Hensley+M%2C+Hudis+C%2C+Ellis+N%2C+Boyd+J%2C+Borgen+P%2C+Barakat+R%2C+Norton+L%2C+Castiel+M%2C+Nafa+K%2C+Offit+K&amp;rft.pages=1609-15&amp;rft_id=info:pmid/12023992&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Fabstract%2FNEJMoa020119v1">&#160;</span></li>
<li id="_note-18"><b><a href="#_ref-18" title="">^</a></b> <a href="http://www.brighamandwomens.org/patient/menopauseqanda.asp" class="external autonumber" title="http://www.brighamandwomens.org/patient/menopauseqanda.asp" rel="nofollow">[1]</a><a href="../../../b/r/i/Brigham_and_Women%27s_Hospital_d203.html" title="Brigham and Women's Hospital">Brigham and Women's Hospital</a>, <a href="../../../b/o/s/Boston%2C_Massachusetts_d688.html" title="Boston, Massachusetts">Boston, Massachusetts</a>.</li>
<li id="_note-19"><b><a href="#_ref-19" title="">^</a></b> <a href="http://jncicancerspectrum.oxfordjournals.org/cgi/content/abstract/jnci;87/22/1681" class="external text" title="http://jncicancerspectrum.oxfordjournals.org/cgi/content/abstract/jnci;87/22/1681" rel="nofollow">Madigan MP, Zielgler RG, Benichou J, Bryne C, Hoover RN (1995). Proportion of breast cancer cases in the United States explained by well-established risk factors. Journal of the National Cancer Institute 87: 1681-85.</a></li>
<li id="_note-20"><b><a href="#_ref-20" title="">^</a></b> <a href="http://www.safecosmetics.org" class="external text" title="http://www.safecosmetics.org" rel="nofollow">Campaign for Safe Cosmetics</a></li>
<li id="_note-21"><b><a href="#_ref-21" title="">^</a></b> <cite style="font-style:normal">Elwood J, Cox B, Richardson A. "The effectiveness of breast cancer screening by mammography in younger women.". <i>Online J Curr Clin Trials</i> <b>Doc No 32</b>: [23,227 words; 195 paragraphs]. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8305999" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8305999">PMID 8305999</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+effectiveness+of+breast+cancer+screening+by+mammography+in+younger+women.&amp;rft.title=Online+J+Curr+Clin+Trials&amp;rft.jtitle=Online+J+Curr+Clin+Trials&amp;rft.volume=Doc+No+32&amp;rft.au=Elwood+J%2C+Cox+B%2C+Richardson+A&amp;rft.pages=%5B23%2C227+words%3B+195+paragraphs%5D">&#160;</span></li>
<li id="_note-22"><b><a href="#_ref-22" title="">^</a></b> <cite style="font-style:normal">Fletcher S, Black W, Harris R, Rimer B, Shapiro S (1993). "Report of the International Workshop on Screening for Breast Cancer.". <i>J Natl Cancer Inst</i> <b>85</b> (20): 1644-56. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8105098" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8105098">PMID 8105098</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Report+of+the+International+Workshop+on+Screening+for+Breast+Cancer.&amp;rft.title=J+Natl+Cancer+Inst&amp;rft.jtitle=J+Natl+Cancer+Inst&amp;rft.date=1993&amp;rft.volume=85&amp;rft.issue=20&amp;rft.au=Fletcher+S%2C+Black+W%2C+Harris+R%2C+Rimer+B%2C+Shapiro+S&amp;rft.pages=1644-56">&#160;</span></li>
<li id="_note-23"><b><a href="#_ref-23" title="">^</a></b> <cite style="font-style:normal">Hrung J, Sonnad S, Schwartz J, Langlotz C (1999). "Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis.". <i>Acad Radiol</i> <b>6</b> (7): 387-97. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10410164" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10410164">PMID 10410164</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Accuracy+of+MR+imaging+in+the+work-up+of+suspicious+breast+lesions%3A+a+diagnostic+meta-analysis.&amp;rft.title=Acad+Radiol&amp;rft.jtitle=Acad+Radiol&amp;rft.date=1999&amp;rft.volume=6&amp;rft.issue=7&amp;rft.au=Hrung+J%2C+Sonnad+S%2C+Schwartz+J%2C+Langlotz+C&amp;rft.pages=387-97">&#160;</span></li>
<li id="_note-24"><b><a href="#_ref-24" title="">^</a></b> <cite style="font-style:normal">Morrow M (2004). "Magnetic resonance imaging in breast cancer: one step forward, two steps back?". <i>JAMA</i> <b>292</b> (22): 2779-80. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15585740" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15585740">PMID 15585740</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Magnetic+resonance+imaging+in+breast+cancer%3A+one+step+forward%2C+two+steps+back%3F&amp;rft.title=JAMA&amp;rft.jtitle=JAMA&amp;rft.date=2004&amp;rft.volume=292&amp;rft.issue=22&amp;rft.au=Morrow+M&amp;rft.pages=2779-80">&#160;</span></li>
<li id="_note-25"><b><a href="#_ref-25" title="">^</a></b> "<a href="http://news.bbc.co.uk/1/hi/health/1601267.stm" class="external text" title="http://news.bbc.co.uk/1/hi/health/1601267.stm" rel="nofollow">Women 'misjudge screening benefits'</a>", <i>BBC</i>, Monday, 15 October, 2001. Retrieved on <a href="../../../a/p/r/April_4.html" title="April 4">April 4</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-26"><b><a href="#_ref-26" title="">^</a></b> <cite style="font-style:normal">Olsen O, Gøtzsche P (2001). "Cochrane review on screening for breast cancer with mammography". <i>Lancet</i> <b>358</b> (9290): 1340-2. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11684218" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11684218">PMID 11684218</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Cochrane+review+on+screening+for+breast+cancer+with+mammography&amp;rft.title=Lancet&amp;rft.jtitle=Lancet&amp;rft.date=2001&amp;rft.volume=358&amp;rft.issue=9290&amp;rft.au=Olsen+O%2C+G%C3%B8tzsche+P&amp;rft.pages=1340-2&amp;rft_id=info:pmid/11684218">&#160;</span></li>
<li id="_note-27"><b><a href="#_ref-27" title="">^</a></b> "<a href="http://news.bbc.co.uk/1/hi/health/1607113.stm" class="external text" title="http://news.bbc.co.uk/1/hi/health/1607113.stm" rel="nofollow">New concerns over breast screening</a>", <i>BBC</i>, Thursday, 18 October, 2001. Retrieved on <a href="../../../a/p/r/April_4.html" title="April 4">April 4</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-28"><b><a href="#_ref-28" title="">^</a></b> Rusiecki JA, Holford TR, Zahm SH, Zheng T. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev 2005;29:419-26</li>
<li id="_note-29"><b><a href="#_ref-29" title="">^</a></b> <a href="http://www.cancer.gov/cancertopics/factsheet/therapy/herceptin," class="external text" title="http://www.cancer.gov/cancertopics/factsheet/therapy/herceptin," rel="nofollow">accessed 1/30/07 cancer.gov</a></li>
<li id="_note-NewsMax"><b><a href="#_ref-NewsMax_0" title="">^</a></b> "<a href="http://newsmax.com/archives/articles/2007/2/6/130740.shtml" class="external text" title="http://newsmax.com/archives/articles/2007/2/6/130740.shtml" rel="nofollow">FDA Approves New Breast Cancer Test</a>". <a href="../../../a/s/s/Associated_Press_9ff2.html" title="Associated Press">Associated Press</a>, <a href="../../../f/e/b/February_6.html" title="February 6">February 6</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-30"><b><a href="#_ref-30" title="">^</a></b> J. Bennet (2006). <a href="http://www.accc-cancer.org/onis/articles/marapr06/bennett.pdf" class="external text" title="http://www.accc-cancer.org/onis/articles/marapr06/bennett.pdf" rel="nofollow">Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma</a>.(pdf)</li>
<li id="_note-31"><b><a href="#_ref-31" title="">^</a></b> <a href="http://www.cancer.gov/cancertopics/pdq/treatment/breast/HealthProfessional/page7#Section_251" class="external text" title="http://www.cancer.gov/cancertopics/pdq/treatment/breast/HealthProfessional/page7#Section_251" rel="nofollow">cancer.gov</a></li>
<li id="_note-32"><b><a href="#_ref-32" title="">^</a></b> Vaidya J. <a href="http://www.dundee.ac.uk/surgery/targit/targitpapers.htm" class="external text" title="http://www.dundee.ac.uk/surgery/targit/targitpapers.htm" rel="nofollow">TARGIT (TARGeted Intraoperative radioTherapy)</a>. Retrieved on <a href="../../../m/a/r/March_11.html" title="March 11">March 11</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-Vaidya_2000"><b><a href="#_ref-Vaidya_2000_0" title="">^</a></b> Vaidya J, Tobias J, Baum M, Houghton J. <a href="http://www.thelancet.com/journals/lancet/misc/protocol/99PRT-47" class="external text" title="http://www.thelancet.com/journals/lancet/misc/protocol/99PRT-47" rel="nofollow">Protocol 99PRT/47 Targeted Intraoperative radiotherapy (Targit) for breast cancer</a>. Retrieved on <a href="../../../m/a/r/March_11.html" title="March 11">March 11</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-Vaidya_2006"><b><a href="#_ref-Vaidya_2006_0" title="">^</a></b> <cite style="font-style:normal">Vaidya J, Baum M, Tobias J, Massarut S, Wenz F, Murphy O, Hilaris B, Houghton J, Saunders C, Corica T, Roncadin M, Kraus-Tiefenbacher U, Melchaert F, Keshtgar M, Sainsbury R, Douek M, Harrison E, Thompson A, Joseph D (2006). "Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost". <i>Int J Radiat Oncol Biol Phys</i> <b>66</b> (5): 1335-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17084562" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17084562">PMID 17084562</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Targeted+intraoperative+radiotherapy+%28TARGIT%29+yields+very+low+recurrence+rates+when+given+as+a+boost&amp;rft.title=Int+J+Radiat+Oncol+Biol+Phys&amp;rft.jtitle=Int+J+Radiat+Oncol+Biol+Phys&amp;rft.date=2006&amp;rft.volume=66&amp;rft.issue=5&amp;rft.au=Vaidya+J%2C+Baum+M%2C+Tobias+J%2C+Massarut+S%2C+Wenz+F%2C+Murphy+O%2C+Hilaris+B%2C+Houghton+J%2C+Saunders+C%2C+Corica+T%2C+Roncadin+M%2C+Kraus-Tiefenbacher+U%2C+Melchaert+F%2C+Keshtgar+M%2C+Sainsbury+R%2C+Douek+M%2C+Harrison+E%2C+Thompson+A%2C+Joseph+D&amp;rft.pages=1335-8&amp;rft_id=info:pmid/17084562">&#160;</span></li>
<li id="_note-33"><b><a href="#_ref-33" title="">^</a></b> <a href="http://www.dundee.ac.uk/surgery/targit/targitpapers.htm" class="external text" title="http://www.dundee.ac.uk/surgery/targit/targitpapers.htm" rel="nofollow">Targit literature Website</a></li>
<li id="_note-34"><b><a href="#_ref-34" title="">^</a></b> <cite style="font-style:normal">Wang, L et al (2005). "The inhibitory effect of flaxseed oil on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components". <i>International Journal of Cancer</i> <b>116</b> (5): 793-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15849746" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15849746">PMID 15849746</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+inhibitory+effect+of+flaxseed+oil+on+the+growth+and+metastasis+of+estrogen+receptor+negative+human+breast+cancer+xenografts+is+attributed+to+both+its+lignan+and+oil+components&amp;rft.title=International+Journal+of+Cancer&amp;rft.jtitle=International+Journal+of+Cancer&amp;rft.date=2005&amp;rft.volume=116&amp;rft.issue=5&amp;rft.au=Wang%2C+L+et+al&amp;rft.pages=793-8">&#160;</span></li>
<li id="_note-35"><b><a href="#_ref-35" title="">^</a></b> <cite style="font-style:normal">Thompson, LU et al (2005). "Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer". <i>Clinical Cancer Research</i> <b>11</b> (10): 3828-35. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15897583" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15897583">PMID 15897583</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Dietary+flaxseed+alters+tumor+biological+markers+in+postmenopausal+breast+cancer&amp;rft.title=Clinical+Cancer+Research&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.date=2005&amp;rft.volume=11&amp;rft.issue=10&amp;rft.au=Thompson%2C+LU+et+al&amp;rft.pages=3828-35">&#160;</span></li>
<li id="_note-36"><b><a href="#_ref-36" title="">^</a></b> <cite style="font-style:normal">Chen, J et al (2004). "Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice". <i>Clinical Cancer Research</i> <b>10</b> (22): 7703-11. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15570004" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15570004">PMID 15570004</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Dietary+flaxseed+enhances+the+inhibitory+effect+of+tamoxifen+on+the+growth+of+estrogen-dependent+human+breast+cancer+%28mcf-7%29+in+nude+mice&amp;rft.title=Clinical+Cancer+Research&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.date=2004&amp;rft.volume=10&amp;rft.issue=22&amp;rft.au=Chen%2C+J+et+al&amp;rft.pages=7703-11">&#160;</span></li>
<li id="_note-37"><b><a href="#_ref-37" title="">^</a></b> <cite style="font-style:normal">Chen, J et al (2002). "Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor". <i>Nutrition and Cancer</i> <b>43</b> (2): 187-92. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12588699" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12588699">PMID 12588699</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Dietary+flaxseed+inhibits+human+breast+cancer+growth+and+metastasis+and+downregulates+expression+of+insulin-like+growth+factor+and+epidermal+growth+factor+receptor&amp;rft.title=Nutrition+and+Cancer&amp;rft.jtitle=Nutrition+and+Cancer&amp;rft.date=2002&amp;rft.volume=43&amp;rft.issue=2&amp;rft.au=Chen%2C+J+et+al&amp;rft.pages=187-92">&#160;</span></li>
<li id="_note-AMN"><b><a href="#_ref-AMN_0" title="">^</a></b> Armando E. Giuliano, MD (May 31 2006). <a href="http://www.health.am/cr/more/carcinoma-of-the-male-breast/" class="external text" title="http://www.health.am/cr/more/carcinoma-of-the-male-breast/" rel="nofollow">Carcinoma of the Male Breast - General Considerations</a>. <i>Breast Cancer</i>. Retrieved on <a href="../../../f/e/b/February_27.html" title="February 27">February 27</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://dmoz.org//Health/Conditions_and_Diseases/Cancer/Breast/" class="external text" title="http://dmoz.org//Health/Conditions_and_Diseases/Cancer/Breast/" rel="nofollow">Breast cancer</a> at the <a href="../../../o/p/e/Open_Directory_Project_505b.html" title="Open Directory Project">Open Directory Project</a> <small>(<a href="http://dmoz.org/cgi-bin/add.cgi?where=/Health/Conditions_and_Diseases/Cancer/Breast/" class="external text" title="http://dmoz.org/cgi-bin/add.cgi?where=/Health/Conditions_and_Diseases/Cancer/Breast/" rel="nofollow">suggest site</a>)</small></li>
</ul>
<p><a name="General" id="General"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: General">edit</a>]</span> <span class="mw-headline">General</span></h3>
<ul>
<li><a href="http://www.nci.nih.gov/cancertopics/types/breast" class="external text" title="http://www.nci.nih.gov/cancertopics/types/breast" rel="nofollow">National Cancer Institute - Breast Cancer Home Page</a></li>
<li><a href="http://www.breastcancercampaign.org/files/WhatIsBreastCancer/pdf/historyofbreastcancer.pdf" class="external text" title="http://www.breastcancercampaign.org/files/WhatIsBreastCancer/pdf/historyofbreastcancer.pdf" rel="nofollow">History of breast cancer treatment</a></li>
<li><a href="http://www.health.am/cr/breast-cancer/" class="external text" title="http://www.health.am/cr/breast-cancer/" rel="nofollow">The Breast: Neoplasms of the Breast</a></li>
</ul>
<p><a name="Research_and_statistics" id="Research_and_statistics"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Research and statistics">edit</a>]</span> <span class="mw-headline">Research and statistics</span></h3>
<ul>
<li><a href="../../../i/n/t/International_Agency_for_Research_on_Cancer_a720.html" title="International Agency for Research on Cancer">International Agency for Research on Cancer</a> <a href="http://www.iarc.fr/" class="external text" title="http://www.iarc.fr/" rel="nofollow">home page</a></li>
<li><a href="http://www.nationmaster.com/graph/hea_bre_can_inc-health-breast-cancer-incidence" class="external text" title="http://www.nationmaster.com/graph/hea_bre_can_inc-health-breast-cancer-incidence" rel="nofollow">Breast cancer incidence by country</a></li>
<li><a href="http://healthnet.1111mb.com/2007/04/breast-cancer-genetic-risk-factors.html" class="external text" title="http://healthnet.1111mb.com/2007/04/breast-cancer-genetic-risk-factors.html" rel="nofollow">Breast Cancer Genetic Risk Factors</a>. NLM. Retrieved on <a href="../../../a/p/r/April_7.html" title="April 7">April 7</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>. video</li>
</ul>
<p><a name="Clinical" id="Clinical"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Clinical">edit</a>]</span> <span class="mw-headline">Clinical</span></h3>
<ul>
<li><a href="http://www.radiologyinfo.org/en/info.cfm?pg=breastcancer" class="external text" title="http://www.radiologyinfo.org/en/info.cfm?pg=breastcancer" rel="nofollow">RadiologyInfo</a> - The radiology information resource for patients: Breast Cancer</li>
<li><a href="http://www.center4research.org/pdf/booklet04bc.pdf" class="external text" title="http://www.center4research.org/pdf/booklet04bc.pdf" rel="nofollow">Surgery Choices for Women with Early-Stage Breast Cancer, National Cancer Institute</a></li>
<li><a href="http://www.center4research.org/bc071502.html" class="external text" title="http://www.center4research.org/bc071502.html" rel="nofollow">Mastectomy vs.n Lumpectomy: Who Decides?, National Research Center for Women &amp; Families</a></li>
<li>Australia: <i>Cancer Control Bulletin</i> <a href="http://www.sesiahs.health.nsw.gov.au/publications/cancerControl/26%20Alcohol.PDF" class="external text" title="http://www.sesiahs.health.nsw.gov.au/publications/cancerControl/26%20Alcohol.PDF" rel="nofollow">Alcohol and cancer risk</a></li>
<li><a href="../../../c/o/r/Cornell_University_7419.html" title="Cornell University">Cornell University</a> <a href="http://envirocancer.cornell.edu/FactSheet/Diet/fs13.alcohol.cfm" class="external text" title="http://envirocancer.cornell.edu/FactSheet/Diet/fs13.alcohol.cfm" rel="nofollow">Alcohol and the Risk of Breast Cancer</a></li>
</ul>
<p><a name="Other" id="Other"></a></p>
<h3><span class="editsection">[<a href="../../../b/r/e/Breast_cancer.html" title="Edit section: Other">edit</a>]</span> <span class="mw-headline">Other</span></h3>
<ul>
<li><a href="http://www.mayoclinic.org/tradition-heritage/grading-cancerous-tumors.html" class="external text" title="http://www.mayoclinic.org/tradition-heritage/grading-cancerous-tumors.html" rel="nofollow">Mayo Clinic: How the grading system for cancerous tumors was developed.</a></li>
<li><a href="http://www.patientpower.info/programsbytopicdetails.asp?Topic=Breast%20Cancer" class="external text" title="http://www.patientpower.info/programsbytopicdetails.asp?Topic=Breast%20Cancer" rel="nofollow">Interviews with Breast Cancer Experts</a></li>
<li><a href="http://healthnet.1111mb.com/2007/04/breast-cancer-surviving-breast-cancer.html" class="external text" title="http://healthnet.1111mb.com/2007/04/breast-cancer-surviving-breast-cancer.html" rel="nofollow">Surviving Breast Cancer</a>. NLM. Retrieved on <a href="../../../a/p/r/April_7.html" title="April 7">April 7</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>. video</li>
</ul>
<div class="NavFrame" style="clear:both;">
<div class="NavHead">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../t/u/m/Template%7ETumors_06b1.html" title="Template:Tumors"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../t/u/m/Template%7ETumors_06b1.html" class="external text" title="http://en.wikipedia.org../../../t/u/m/Template%7ETumors_06b1.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../p/a/t/Pathology.html" title="Pathology">Pathology</a>: <a href="../../../t/u/m/Tumor.html" title="Tumor">tumors</a> (and related structures), <a href="../../../c/a/n/Cancer.html" title="Cancer">cancer</a>, and <a href="../../../o/n/c/Oncology.html" title="Oncology">oncology</a> (<a href="../../../n/e/o/ICD-10_Chapter_II%7E_Neoplasms%3B_Chapter_III%7E_Diseases_of_the_blood_and_blood-forming_organs%2C_and_certain_disorders_involving_the_immune_mechanism_1046.html" title="ICD-10 Chapter II: Neoplasms; Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism">C00-D48</a>)</b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><a href="../../../b/e/n/Benign.html" title="Benign">Benign</a> - <a href="../../../p/r/e/Premalignant_condition.html" title="Premalignant condition">Premalignant</a> - <a href="../../../c/a/r/Carcinoma_in_situ.html" title="Carcinoma in situ">Carcinoma in situ</a> - <a href="../../../m/a/l/Malignant.html" title="Malignant">Malignant</a></p>
<p><i>Topography:</i> <a href="../../../a/n/a/Anal_cancer.html" title="Anal cancer">Anus</a> - <a href="../../../b/l/a/Bladder_cancer.html" title="Bladder cancer">Bladder</a> - <a href="../../../c/h/o/Cholangiocarcinoma.html" title="Cholangiocarcinoma">Bile duct</a> - <a href="../../../b/o/n/Bone_tumor.html" title="Bone tumor">Bone</a> - <a href="../../../b/r/a/Brain_tumor.html" title="Brain tumor">Brain</a> - <strong class="selflink">Breast</strong> - <a href="../../../c/e/r/Cervical_cancer.html" title="Cervical cancer">Cervix</a> - <a href="../../../c/o/l/Colorectal_cancer.html" title="Colorectal cancer">Colon/rectum</a> - <a href="../../../d/u/o/Duodenal_cancer.html" title="Duodenal cancer">Duodenum</a> - <a href="../../../e/n/d/Endometrial_cancer.html" title="Endometrial cancer">Endometrium</a> - <a href="../../../e/s/o/Esophageal_cancer.html" title="Esophageal cancer">Esophagus</a> - <a href="../../../o/c/u/Ocular_oncology.html" title="Ocular oncology">Eye</a> - <a href="../../../g/a/l/Gallbladder_cancer.html" title="Gallbladder cancer">Gallbladder</a> - <a href="../../../h/e/a/Head_and_neck_cancer.html" title="Head and neck cancer">Head/Neck</a> - <a href="../../../h/e/p/Hepatocellular_carcinoma.html" title="Hepatocellular carcinoma">Liver</a> - <a href="../../../c/a/n/Cancer_of_the_larynx.html" title="Cancer of the larynx">Larynx</a> - <a href="../../../l/u/n/Lung_cancer.html" title="Lung cancer">Lung</a> - <a href="../../../o/r/a/Oral_cancer.html" title="Oral cancer">Mouth</a> - <a href="../../../p/a/n/Pancreatic_cancer.html" title="Pancreatic cancer">Pancreas</a> - <a href="../../../p/e/n/Penile_cancer.html" title="Penile cancer">Penis</a> - <a href="../../../p/r/o/Prostate_cancer.html" title="Prostate cancer">Prostate</a> - <a href="../../../r/e/n/Renal_cell_carcinoma.html" title="Renal cell carcinoma">Kidney</a> - <a href="../../../o/v/a/Ovarian_cancer.html" title="Ovarian cancer">Ovaries</a> - <a href="../../../s/k/i/Skin_cancer.html" title="Skin cancer">Skin</a> - <a href="../../../s/t/o/Stomach_cancer.html" title="Stomach cancer">Stomach</a> - <a href="../../../t/e/s/Testicular_cancer.html" title="Testicular cancer">Testicles</a> - <a href="../../../t/h/y/Thyroid_cancer.html" title="Thyroid cancer">Thyroid</a></p>
<p><i>Morphology:</i> <a href="../../../p/a/p/Papilloma.html" title="Papilloma">Papilloma</a>/<a href="../../../c/a/r/Carcinoma.html" title="Carcinoma">carcinoma</a> - <a href="../../../c/h/o/Choriocarcinoma.html" title="Choriocarcinoma">Choriocarcinoma</a> - <a href="../../../a/d/e/Adenoma.html" title="Adenoma">Adenoma</a>/<a href="../../../a/d/e/Adenocarcinoma.html" title="Adenocarcinoma">adenocarcinoma</a> - <a href="../../../s/o/f/Soft_tissue_sarcoma.html" title="Soft tissue sarcoma">Soft tissue sarcoma</a> - <a href="../../../m/e/l/Melanoma.html" title="Melanoma">Melanoma</a> - <a href="../../../f/i/b/Fibroma.html" title="Fibroma">Fibroma</a>/<a href="../../../f/i/b/Fibrosarcoma.html" title="Fibrosarcoma">fibrosarcoma</a> - <a href="../../../m/e/t/Metastasis.html" title="Metastasis">Metastasis</a> - <a href="../../../l/i/p/Lipoma.html" title="Lipoma">Lipoma</a>/<a href="../../../l/i/p/Liposarcoma.html" title="Liposarcoma">liposarcoma</a> - <a href="../../../l/e/i/Leiomyoma.html" title="Leiomyoma">Leiomyoma</a>/<a href="../../../l/e/i/Leiomyosarcoma.html" title="Leiomyosarcoma">leiomyosarcoma</a> - <a href="../../../r/h/a/Rhabdomyoma.html" title="Rhabdomyoma">Rhabdomyoma</a>/<a href="../../../r/h/a/Rhabdomyosarcoma.html" title="Rhabdomyosarcoma">rhabdomyosarcoma</a> - <a href="../../../m/e/s/Mesothelioma.html" title="Mesothelioma">Mesothelioma</a> - <a href="../../../a/n/g/Angioma.html" title="Angioma">Angioma</a>/<a href="../../../a/n/g/Angiosarcoma.html" title="Angiosarcoma">angiosarcoma</a> - <a href="../../../o/s/t/Osteoma.html" title="Osteoma">Osteoma</a>/<a href="../../../o/s/t/Osteosarcoma.html" title="Osteosarcoma">osteosarcoma</a> - <a href="../../../c/h/o/Chondroma.html" title="Chondroma">Chondroma</a>/<a href="../../../c/h/o/Chondrosarcoma.html" title="Chondrosarcoma">chondrosarcoma</a> - <a href="../../../g/l/i/Glioma.html" title="Glioma">Glioma</a> - <a href="../../../l/y/m/Lymphoma.html" title="Lymphoma">Lymphoma</a>/<a href="../../../l/e/u/Leukemia.html" title="Leukemia">leukemia</a></p>
<p><i>Treatment:</i> <a href="../../../s/u/r/Surgery.html" title="Surgery">Surgery</a> - <a href="../../../c/h/e/Chemotherapy.html" title="Chemotherapy">Chemotherapy</a> - <a href="../../../r/a/d/Radiation_therapy.html" title="Radiation therapy">Radiation therapy</a> - <a href="../../../c/a/n/Cancer_immunotherapy.html" title="Cancer immunotherapy">Immunotherapy</a> - <a href="../../../e/x/p/Experimental_cancer_treatment.html" title="Experimental cancer treatment">Experimental cancer treatment</a></p>
<p><i>Related structures:</i> <a href="../../../c/y/s/Cyst.html" title="Cyst">Cyst</a> - <a href="../../../d/y/s/Dysplasia.html" title="Dysplasia">Dysplasia</a> - <a href="../../../h/a/m/Hamartoma.html" title="Hamartoma">Hamartoma</a> - <a href="../../../n/e/o/Neoplasia.html" title="Neoplasia">Neoplasia</a> - <a href="../../../n/o/d/Nodule_%28medicine%29.html" title="Nodule (medicine)">Nodule</a> - <a href="../../../p/o/l/Polyp_%28medicine%29.html" title="Polyp (medicine)">Polyp</a> - <a href="../../../p/s/e/Pseudocyst.html" title="Pseudocyst">Pseudocyst</a></p>
<p><i>Misc:</i> <a href="../../../t/u/m/Tumor_suppressor_gene.html" title="Tumor suppressor gene">Tumor suppressor genes</a>/<a href="../../../o/n/c/Oncogene.html" title="Oncogene">oncogenes</a> - <a href="../../../c/a/n/Cancer_staging.html" title="Cancer staging">Staging</a>/<a href="../../../g/r/a/Grading_%28tumors%29.html" title="Grading (tumors)">grading</a> - <a href="../../../c/a/r/Carcinogenesis.html" title="Carcinogenesis">Carcinogenesis</a>/<a href="../../../m/e/t/Metastasis.html" title="Metastasis">metastasis</a> - <a href="../../../c/a/r/Carcinogen.html" title="Carcinogen">Carcinogen</a> - <a href="../../../c/a/n/Cancer_research.html" title="Cancer research">Research</a> - <a href="../../../p/a/r/Paraneoplastic_phenomenon.html" title="Paraneoplastic phenomenon">Paraneoplastic phenomenon</a> - <a href="../../../i/c/d/ICD-O_d226.html" title="ICD-O">ICD-O</a> - <a href="../../../l/i/s/List_of_oncology-related_terms.html" title="List of oncology-related terms">List of oncology-related terms</a></p>
</div>
</div>
<p><span id="interwiki-he-fa"></span> <span id="interwiki-vi-fa"></span></p>

<!-- 
Pre-expand include size: 205727 bytes
Post-expand include size: 81783 bytes
Template argument size: 58394 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/r/e/Breast_cancer.html">http://en.wikipedia.org../../../b/r/e/Breast_cancer.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_February_2007_f7dc.html" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_with_unsourced_statements_2f67.html" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_March_2007_2536.html" title="Category:Articles with unsourced statements since March 2007">Articles with unsourced statements since March 2007</a></span> | <span dir='ltr'><a href="../../../g/y/n/Category%7EGynecology_cc4e.html" title="Category:Gynecology">Gynecology</a></span> | <span dir='ltr'><a href="../../../t/y/p/Category%7ETypes_of_cancer_e9ea.html" title="Category:Types of cancer">Types of cancer</a></span> | <span dir='ltr'><a href="../../../b/r/e/Category%7EBreast_255c.html" title="Category:Breast">Breast</a></span> | <span dir='ltr'><a href="../../../r/i/b/Category%7ERibbon_symbolism_bdc0.html" title="Category:Ribbon symbolism">Ribbon symbolism</a></span> | <span dir='ltr'><a href="../../../h/e/r/Category%7EHereditary_cancers_826e.html" title="Category:Hereditary cancers">Hereditary cancers</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/r/e/Breast_cancer.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../b/r/e/Talk%7EBreast_cancer_ab45.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Breast_cancer">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../ar/%D8%B3/%D8%B1/%D8%B7/%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D8%A7%D9%84%D8%AB%D8%AF%D9%8A.html">العربية</a>
	      </li>
	      	      <li>
	      <a href="../../../../bs/t/u/m/Tumori_dojke.html">Bosanski</a>
	      </li>
	      	      <li>
	      <a href="../../../../bg/%D1%80/%D0%B0/%D0%BA/%D0%A0%D0%B0%D0%BA_%D0%BD%D0%B0_%D0%B3%D1%8A%D1%80%D0%B4%D0%B0%D1%82%D0%B0.html">Български</a>
	      </li>
	      	      <li>
	      <a href="../../../../da/b/r/y/Brystkr%C3%A6ft.html">Dansk</a>
	      </li>
	      	      <li>
	      <a href="../../../../de/b/r/u/Brustkrebs.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/c/%C3%A1/n/C%C3%A1ncer_de_mama.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/c/a/n/Cancer_du_sein.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../hr/r/a/k/Rak_dojke.html">Hrvatski</a>
	      </li>
	      	      <li>
	      <a href="../../../../id/k/a/n/Kanker_payudara.html">Bahasa Indonesia</a>
	      </li>
	      	      <li>
	      <a href="../../../../it/c/a/r/Carcinoma_mammario.html">Italiano</a>
	      </li>
	      	      <li>
	      <a href="../../../../he/%D7%A1/%D7%A8/%D7%98/%D7%A1%D7%A8%D7%98%D7%9F_%D7%94%D7%A9%D7%93.html">עברית</a>
	      </li>
	      	      <li>
	      <a href="../../../../mk/%D1%80/%D0%B0/%D0%BA/%D0%A0%D0%B0%D0%BA_%D0%BD%D0%B0_%D0%B4%D0%BE%D1%98%D0%BA%D0%B0.html">Македонски</a>
	      </li>
	      	      <li>
	      <a href="../../../../ms/p/e/n/Penyakit_barah_payu_dara.html">Bahasa Melayu</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/b/o/r/Borstkanker.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E4%B9%B3/%E7%99%8C/_/%E4%B9%B3%E7%99%8C.html">日本語</a>
	      </li>
	      	      <li>
	      <a href="../../../../no/b/r/y/Brystkreft.html">‪Norsk (bokmål)‬</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/r/a/k/Rak_sutka.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/c/%C3%A2/n/C%C3%A2ncer_de_mama.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/%D0%B7/%D0%BB/%D0%BE/%D0%97%D0%BB%D0%BE%D0%BA%D0%B0%D1%87%D0%B5%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D0%B5_%D0%BD%D0%BE%D0%B2%D0%BE%D0%BE%D0%B1%D1%80%D0%B0%D0%B7%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%BC%D0%BE%D0%BB%D0%BE%D1%87%D0%BD%D0%BE%D0%B9_%D0%B6%D0%B5%D0%BB%D0%B5%D0%B7%D1%8B.html">Русский</a>
	      </li>
	      	      <li>
	      <a href="../../../../sk/k/a/r/Karcin%C3%B3m_prsn%C3%ADka.html">Slovenčina</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/r/i/n/Rintasy%C3%B6p%C3%A4.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/b/r/%C3%B6/Br%C3%B6stcancer.html">Svenska</a>
	      </li>
	      	      <li>
	      <a href="../../../../th/%E0%B8%A1/%E0%B8%B0/%E0%B9%80/%E0%B8%A1%E0%B8%B0%E0%B9%80%E0%B8%A3%E0%B9%87%E0%B8%87%E0%B9%80%E0%B8%95%E0%B9%89%E0%B8%B2%E0%B8%99%E0%B8%A1.html">ไทย</a>
	      </li>
	      	      <li>
	      <a href="../../../../vi/u/n/g/Ung_th%C6%B0_v%C3%BA.html">Tiếng Việt</a>
	      </li>
	      	      <li>
	      <a href="../../../../tr/m/e/m/Meme_Kanseri_5cf1.html">Türkçe</a>
	      </li>
	      	      <li>
	      <a href="../../../../ur/%D8%B3/%D8%B1/%D8%B7/%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D9%BE%D8%B3%D8%AA%D8%A7%D9%86.html">اردو</a>
	      </li>
	      	      <li>
	      <a href="../../../../zh/%E4%B9%B3/%E7%99%8C/_/%E4%B9%B3%E7%99%8C.html">中文</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 02:43, 8 April 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../e/z/e/User%7EEzeu_f517.html" title="User:Ezeu">Ezeu</a>, <a href="../../../n/b/a/User%7ENbauman_bc94.html" title="User:Nbauman">Nbauman</a>, ChanningLaurel, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../s/t/e/User%7EStephP_6b99.html" title="User:StephP">StephP</a>, <a href="../../../s/f/m/User%7ESfmammamia_60a6.html" title="User:Sfmammamia">Sfmammamia</a>, <a href="../../../s/h/a/User%7EShadowlynk_6f44.html" title="User:Shadowlynk">Shadowlynk</a>, <a href="../../../d/r/o/User%7EDroliver_c7f0.html" title="User:Droliver">Droliver</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../b/o/r/User%7EBorn2x_2820.html" title="User:Born2x">Born2x</a>, L'Eagle, <a href="../../../m/a/t/User%7EMatthew_W_8a5f.html" title="User:Matthew W">Matthew W</a>, Sseretti84, <a href="../../../l/c/a/User%7ELcarscad_ebff.html" title="User:Lcarscad">Lcarscad</a>, MailMan6, <a href="../../../m/a/r/User%7EMartinBot_3f64.html" title="User:MartinBot">MartinBot</a>, <a href="../../../d/d/i/User%7EDDima_3374.html" title="User:DDima">DDima</a>, <a href="../../../j/e/w/User%7EJew091_a111.html" title="User:Jew091">Jew091</a>, <a href="../../../o/r/d/User%7EOrdinary_Person_f894.html" title="User:Ordinary Person">Ordinary Person</a>, Grecofski, <a href="../../../w/i/m/User%7EWimt_5387.html" title="User:Wimt">Wimt</a>, <a href="../../../m/a/r/User%7EMarcoTolo_8040.html" title="User:MarcoTolo">MarcoTolo</a>, <a href="../../../m/i/k/User%7EMike_Rosoft_96ed.html" title="User:Mike Rosoft">Mike Rosoft</a>, <a href="../../../g/g/r/User%7EGGreeneVa_6b2c.html" title="User:GGreeneVa">GGreeneVa</a>, <a href="../../../h/e/i/User%7EHeimstern_8a02.html" title="User:Heimstern">Heimstern</a>, <a href="../../../g/o/s/User%7EGosgood_e3c8.html" title="User:Gosgood">Gosgood</a>, <a href="../../../s/f/a/User%7ESfacets_25b2.html" title="User:Sfacets">Sfacets</a>, Oliver.gouldthorpe, <a href="../../../s/t/e/User%7ESteinsky_9c79.html" title="User:Steinsky">Steinsky</a>, Bcameron54, <a href="../../../j/o/n/User%7EJon186_ab8e.html" title="User:Jon186">Jon186</a>, <a href="../../../n/o/l/User%7ENol888_08df.html" title="User:Nol888">Nol888</a>, <a href="../../../e/l/i/User%7EElisabeth_Rieping_4c2c.html" title="User:Elisabeth Rieping">Elisabeth Rieping</a>, CortJstr, <a href="../../../r/o/y/User%7ERoyBoy_492a.html" title="User:RoyBoy">RoyBoy</a>, <a href="../../../q/u/i/User%7EQuizzicalBee_728e.html" title="User:QuizzicalBee">QuizzicalBee</a>, <a href="../../../t/i/k/User%7ETikiwont_2b2d.html" title="User:Tikiwont">Tikiwont</a>, Rognar, <a href="../../../a/s/h/User%7EAshlux_3f16.html" title="User:Ashlux">Ashlux</a>, Drzuckerman, <a href="../../../t/o/m/User%7ETommyDaniels_34f8.html" title="User:TommyDaniels">TommyDaniels</a>, Mocha09, <a href="../../../c/a/n/User%7ECan%27t_sleep%2C_clown_will_eat_me_7058.html" title="User:Can't sleep, clown will eat me">Can't sleep, clown will eat me</a>, <a href="../../../e/l/k/User%7EElKevbo_3676.html" title="User:ElKevbo">ElKevbo</a>, <a href="../../../d/r/2E/User%7EDr.Gangino_b71d.html" title="User:Dr.Gangino">Dr.Gangino</a>, <a href="../../../c/m/d/User%7ECmdrObot_0605.html" title="User:CmdrObot">CmdrObot</a>, <a href="../../../d/i/n/User%7EDina_fad9.html" title="User:Dina">Dina</a>, <a href="../../../m/y/a/User%7EMyanw_4457.html" title="User:Myanw">Myanw</a>, <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>, <a href="../../../s/i/r/User%7ESirmelle_83d0.html" title="User:Sirmelle">Sirmelle</a>, Joellyjoel, <a href="../../../s/c/e/User%7ESCEhardt_7145.html" title="User:SCEhardt">SCEhardt</a>, Jledous, Chaneric, <a href="../../../j/o/e/User%7EJoeSmack_29f9.html" title="User:JoeSmack">JoeSmack</a>, Crazycam96, <a href="../../../b/u/r/User%7EBurzmali_9c4c.html" title="User:Burzmali">Burzmali</a>, <a href="../../../s/t/b/User%7ESTBotD_8c4f.html" title="User:STBotD">STBotD</a>, <a href="../../../v/i/c/User%7EVictoria2007_8d81.html" title="User:Victoria2007">Victoria2007</a>, <a href="../../../o/n/o/User%7EOnorem_b6c2.html" title="User:Onorem">Onorem</a>, CrayolaStar, <a href="../../../s/h/a/User%7EShanes_8450.html" title="User:Shanes">Shanes</a>, <a href="../../../d/a/n/User%7EDanielCD_4f74.html" title="User:DanielCD">DanielCD</a>, <a href="../../../n/e/2/User%7ENE2_ab1c.html" title="User:NE2">NE2</a>, Jimbob33000, <a href="../../../o/h/n/User%7EOhnoitsjamie_fc14.html" title="User:Ohnoitsjamie">Ohnoitsjamie</a>, <a href="../../../d/e/l/User%7EDelldot_cc92.html" title="User:Delldot">Delldot</a>, <a href="../../../a/r/m/User%7EArmadilloFromHell_83a4.html" title="User:ArmadilloFromHell">ArmadilloFromHell</a>, <a href="../../../c/h/r/User%7EChristopher_Parham_7957.html" title="User:Christopher Parham">Christopher Parham</a>, <a href="../../../h/u/1/User%7EHu12_d0ca.html" title="User:Hu12">Hu12</a>, <a href="../../../p/a/r/User%7EParticleMan_b973.html" title="User:ParticleMan">ParticleMan</a>, <a href="../../../k/a/i/User%7EKaisershatner_51b9.html" title="User:Kaisershatner">Kaisershatner</a>, <a href="../../../t/h/e/User%7ETheEgyptian_df44.html" title="User:TheEgyptian">TheEgyptian</a>, <a href="../../../a/n/t/User%7EAntandrus_5ef3.html" title="User:Antandrus">Antandrus</a>, <a href="../../../s/h/a/User%7EShadow1_a579.html" title="User:Shadow1">Shadow1</a>, <a href="../../../p/r/o/User%7EProlog_962f.html" title="User:Prolog">Prolog</a>, <a href="../../../m/r/_/User%7EMr_Stephen_33a8.html" title="User:Mr Stephen">Mr Stephen</a>, <a href="../../../s/h/a/User%7EShablog_52b3.html" title="User:Shablog">Shablog</a>, <a href="../../../t/u/b/User%7ETubezone_6e86.html" title="User:Tubezone">Tubezone</a>, Westwind273, <a href="../../../r/a/d/User%7ERadagast83_195a.html" title="User:Radagast83">Radagast83</a>, <a href="../../../p/r/e/User%7EPrestonH_c49c.html" title="User:PrestonH">PrestonH</a>, <a href="../../../a/n/t/User%7EAntiVandalBot_aa84.html" title="User:AntiVandalBot">AntiVandalBot</a>, Mabisa, DanaJayne, BHayes07, Womenshealth, <a href="../../../e/a/g/User%7EEagle_101_bfb5.html" title="User:Eagle 101">Eagle 101</a>, Msmp3, <a href="../../../g/a/r/User%7EGarion96_c83d.html" title="User:Garion96">Garion96</a>, Paul Schofleck, <a href="../../../a/l/n/User%7EAlnoktaBOT_865c.html" title="User:AlnoktaBOT">AlnoktaBOT</a>, <a href="../../../a/n/d/User%7EAndrew73_a1aa.html" title="User:Andrew73">Andrew73</a>, <a href="../../../g/o/g/User%7EGogo_Dodo_6e56.html" title="User:Gogo Dodo">Gogo Dodo</a>, Stuartrocks@gmail.com, <a href="../../../f/i/s/User%7EFisherQueen_a50d.html" title="User:FisherQueen">FisherQueen</a>, Spygirl463, <a href="../../../l/y/r/User%7ELyrl_6da9.html" title="User:Lyrl">Lyrl</a>, <a href="../../../v/e/n/User%7EVenu62_2094.html" title="User:Venu62">Venu62</a>, <a href="../../../c/a/s/User%7ECasiraghitrio_6397.html" title="User:Casiraghitrio">Casiraghitrio</a>, <a href="../../../r/o/m/User%7ERombik_0c7b.html" title="User:Rombik">Rombik</a>, <a href="../../../l/i/a/User%7ELiao_cd5d.html" title="User:Liao">Liao</a>, <a href="../../../v/i/r/User%7EViriiK_838b.html" title="User:ViriiK">ViriiK</a>, <a href="../../../c/h/r/User%7EChris_the_speller_fea2.html" title="User:Chris the speller">Chris the speller</a>, <a href="../../../j/o/h/User%7EJohnClarknew_bbd1.html" title="User:JohnClarknew">JohnClarknew</a>, Medicalan, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, NBCC, <a href="../../../j/s/v/User%7EJsvaidya_130e.html" title="User:Jsvaidya">Jsvaidya</a>, <a href="../../../l/u/n/User%7ELuna_Santin_1cab.html" title="User:Luna Santin">Luna Santin</a>, <a href="../../../l/i/s/User%7ELisa_Irwin_badf.html" title="User:Lisa Irwin">Lisa Irwin</a>, <a href="../../../v/o/a/User%7EVoABot_II_04bf.html" title="User:VoABot II">VoABot II</a>, Xanthus1127, <a href="../../../g/d/o/User%7EGdo01_992f.html" title="User:Gdo01">Gdo01</a>, <a href="../../../e/v/e/User%7EEvercat_8d16.html" title="User:Evercat">Evercat</a>, <a href="../../../s/r/o/User%7ESrose_465a.html" title="User:Srose">Srose</a>, <a href="../../../v/a/l/User%7EVal8_af71.html" title="User:Val8">Val8</a>, Psycosonik, <a href="../../../y/b/b/User%7EYbbor_df13.html" title="User:Ybbor">Ybbor</a>, <a href="../../../p/o/t/User%7EPotaco99_4436.html" title="User:Potaco99">Potaco99</a>, Cccp71, Missann, Agelades, <a href="../../../a/u/s/User%7EAustralian_Matt_b9f1.html" title="User:Australian Matt">Australian Matt</a>, <a href="../../../s/c/o/User%7EScottW_8f9d.html" title="User:ScottW">ScottW</a>, <a href="../../../d/u/b/User%7EDubc0724_51dd.html" title="User:Dubc0724">Dubc0724</a>, <a href="../../../g/r/a/User%7EGraham87_fa35.html" title="User:Graham87">Graham87</a>, <a href="../../../a/x/l/User%7EAxl_2118.html" title="User:Axl">Axl</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, <a href="../../../d/a/k/User%7EDakotaKahn_841e.html" title="User:DakotaKahn">DakotaKahn</a>, <a href="../../../z/z/u/User%7EZzuuzz_ab5e.html" title="User:Zzuuzz">Zzuuzz</a>, <a href="../../../i/n/v/User%7EInvictaHOG_427a.html" title="User:InvictaHOG">InvictaHOG</a>, <a href="../../../a/u/s/User%7EAussieBoy_c82a.html" title="User:AussieBoy">AussieBoy</a>, <a href="../../../h/e/l/User%7EHello32020_9b8b.html" title="User:Hello32020">Hello32020</a>, Missfebruary, <a href="../../../m/%26/n/User%7EM%26NCenarius_7c77.html" title="User:M&amp;NCenarius">M&amp;NCenarius</a>, <a href="../../../r/e/t/User%7ERettetast_0619.html" title="User:Rettetast">Rettetast</a>, <a href="../../../b/o/t/User%7EBot-Schafter_1a19.html" title="User:Bot-Schafter">Bot-Schafter</a>, Mergneed, <a href="../../../d/a/r/User%7EDarry2385_f3e0.html" title="User:Darry2385">Darry2385</a>, <a href="../../../n/i/c/User%7ENick_55c2.html" title="User:Nick">Nick</a>, <a href="../../../t/r/a/User%7ETravelbird_9a21.html" title="User:Travelbird">Travelbird</a>, <a href="../../../h/i/g/User%7EHighInBC_48ba.html" title="User:HighInBC">HighInBC</a>, Nikkidoll, <a href="../../../e/s/p/User%7EEsprit15d_69ef.html" title="User:Esprit15d">Esprit15d</a>, <a href="../../../g/r/e/User%7EGreetingsEarthling_cb6f.html" title="User:GreetingsEarthling">GreetingsEarthling</a>, <a href="../../../s/t/b/User%7ESTBot_bbca.html" title="User:STBot">STBot</a>, Guigui37, <a href="../../../b/o/b/User%7EBobanny_136f.html" title="User:Bobanny">Bobanny</a>, Kaitdancer07, <a href="../../../n/o/r/User%7ENorthernThunder_8b1d.html" title="User:NorthernThunder">NorthernThunder</a>, <a href="../../../h/a/w/User%7EHawkerTyphoon_6353.html" title="User:HawkerTyphoon">HawkerTyphoon</a>, <a href="../../../g/r/a/User%7EGraemeL_c5a8.html" title="User:GraemeL">GraemeL</a>, <a href="../../../j/a/r/User%7EJared_Hunt_1c1b.html" title="User:Jared Hunt">Jared Hunt</a>, <a href="../../../m/i/c/User%7EMichael_Hardy_e932.html" title="User:Michael Hardy">Michael Hardy</a>, <a href="../../../m/w/a/User%7EMwanner_e32b.html" title="User:Mwanner">Mwanner</a>, <a href="../../../j/w/s/User%7EJWSchmidt_1173.html" title="User:JWSchmidt">JWSchmidt</a>, <a href="../../../k/o/a/User%7EKoavf_1790.html" title="User:Koavf">Koavf</a>, <a href="../../../a/n/d/User%7EAndrew_Levine_ad03.html" title="User:Andrew Levine">Andrew Levine</a>, <a href="../../../s/t/e/User%7EStev0_d3b3.html" title="User:Stev0">Stev0</a>, Sunsetcleaningservice, <a href="../../../g/a/i/User%7EGaius_Cornelius_c35a.html" title="User:Gaius Cornelius">Gaius Cornelius</a>, <a href="../../../n/u/n/User%7ENunquam_Dormio_ecde.html" title="User:Nunquam Dormio">Nunquam Dormio</a>, Nataliejost, <a href="../../../t/o/n/User%7ETonycdp_3ebf.html" title="User:Tonycdp">Tonycdp</a>, <a href="../../../s/t/r/User%7EStrait_f702.html" title="User:Strait">Strait</a>, <a href="../../../t/s/p/User%7ETspier2_4c08.html" title="User:Tspier2">Tspier2</a>, <a href="../../../m/a/t/User%7EMattopaedia_a144.html" title="User:Mattopaedia">Mattopaedia</a>, Raevansmd, <a href="../../../d/h/n/User%7EDHN-bot_8c4a.html" title="User:DHN-bot">DHN-bot</a>, <a href="../../../w/o/u/User%7EWouterstomp_b006.html" title="User:Wouterstomp">Wouterstomp</a>, <a href="../../../k/j/o/User%7EKjoonlee_eff3.html" title="User:Kjoonlee">Kjoonlee</a>, <a href="../../../b/o/r/User%7EBorisblue_1bc2.html" title="User:Borisblue">Borisblue</a>, <a href="../../../s/e/w/User%7ESEWilco_ba0d.html" title="User:SEWilco">SEWilco</a>, Hfcom, Eat411, <a href="../../../d/l/2/User%7EDl2000_b92d.html" title="User:Dl2000">Dl2000</a>, Lpfister, <a href="../../../b/o/b/User%7EBobo192_c260.html" title="User:Bobo192">Bobo192</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, Mishmosh, Verbivorous, <a href="../../../c/i/n/User%7ECindery_01fc.html" title="User:Cindery">Cindery</a>, Npang, <a href="../../../a/r/g/User%7EArgon233_2714.html" title="User:Argon233">Argon233</a>, <a href="../../../m/a/l/User%7EMalo_c828.html" title="User:Malo">Malo</a>, BCRF, <a href="../../../2/t/_/User%7E2T_9f31.html" title="User:2T">2T</a>, Paysseh, <a href="../../../o/m/i/User%7EOmicronpersei8_71da.html" title="User:Omicronpersei8">Omicronpersei8</a>, <a href="../../../w/m/a/User%7EWmahan_ede0.html" title="User:Wmahan">Wmahan</a>, <a href="../../../n/a/w/User%7ENawlinWiki_2ff5.html" title="User:NawlinWiki">NawlinWiki</a>, <a href="../../../j/a/r/User%7EJaranda_ee94.html" title="User:Jaranda">Jaranda</a>, <a href="../../../a/p/o/User%7EApocalypse_Now_de38.html" title="User:Apocalypse Now">Apocalypse Now</a>, <a href="../../../e/k/e/User%7EEkem_3ee4.html" title="User:Ekem">Ekem</a>, <a href="../../../a/a/r/User%7EAaron_Brenneman_d498.html" title="User:Aaron Brenneman">Aaron Brenneman</a>, Yeti7, <a href="../../../a/n/d/User%7EAndypandy.UK_6e9d.html" title="User:Andypandy.UK">Andypandy.UK</a>, CancerFighter, <a href="../../../l/i/n/User%7ELindsay658_d7de.html" title="User:Lindsay658">Lindsay658</a>, <a href="../../../m/a/l/User%7EMalcolm_Farmer_a328.html" title="User:Malcolm Farmer">Malcolm Farmer</a>, <a href="../../../g/a/r/User%7EGarzo_81e4.html" title="User:Garzo">Garzo</a>, <a href="../../../v/a/l/User%7EValentinian_be8b.html" title="User:Valentinian">Valentinian</a>, Carmitchel, <a href="../../../b/c/s/User%7EBcsurvivor_08a1.html" title="User:Bcsurvivor">Bcsurvivor</a>, <a href="../../../k/h/u/User%7EKhukri_e3b4.html" title="User:Khukri">Khukri</a>, Gcalm, <a href="../../../g/e/o/User%7EGeoffrey_Gibson_5bc1.html" title="User:Geoffrey Gibson">Geoffrey Gibson</a>, Hooperbloob, <a href="../../../j/a/n/User%7EJane023_325d.html" title="User:Jane023">Jane023</a>, Flosseveryday, MummChampagne, <a href="../../../e/k/r/User%7EEkrub-ntyh_e20b.html" title="User:Ekrub-ntyh">Ekrub-ntyh</a>, Arhino, <a href="../../../k/e/v/User%7EKevin_Breitenstein_8775.html" title="User:Kevin Breitenstein">Kevin Breitenstein</a>, <a href="../../../t/a/w/User%7ETawkerbot2_313a.html" title="User:Tawkerbot2">Tawkerbot2</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../g/r/o/User%7EGroogle_7bb0.html" title="User:Groogle">Groogle</a>, <a href="../../../l/o/g/User%7ELogical2u_96f0.html" title="User:Logical2u">Logical2u</a>, <a href="../../../k/i/s/User%7EKiscica_0ab3.html" title="User:Kiscica">Kiscica</a>, <a href="../../../y/a/m/User%7EYamla_5f07.html" title="User:Yamla">Yamla</a>, Leevo, <a href="../../../%5E/d/e/User%7E%5Edemon.html" title="User:^demon">^demon</a>, <a href="../../../l/a/p/User%7ELapaz_13cf.html" title="User:Lapaz">Lapaz</a>, Biggus56, Lennart.larsen, <a href="../../../m/x/n/User%7EMxn_bd81.html" title="User:Mxn">Mxn</a>, <a href="../../../t/e/c/User%7ETechnicaltechy_56e1.html" title="User:Technicaltechy">Technicaltechy</a>, <a href="../../../p/r/o/User%7EPro-Lick_d9f8.html" title="User:Pro-Lick">Pro-Lick</a>, <a href="../../../k/u/r/User%7EKurtRaschke_b39d.html" title="User:KurtRaschke">KurtRaschke</a>, <a href="../../../a/n/d/User%7EAndbuck_2835.html" title="User:Andbuck">Andbuck</a>, <a href="../../../m/i/c/User%7EMichaelLeonhard_a38b.html" title="User:MichaelLeonhard">MichaelLeonhard</a>, Mihairad, <a href="../../../d/a/v/User%7EDavid.Throop_ff18.html" title="User:David.Throop">David.Throop</a>, <a href="../../../t/o/c/User%7ETocotrienols_5134.html" title="User:Tocotrienols">Tocotrienols</a>, Enterkin, <a href="../../../k/c/o/User%7EKcordina_3fec.html" title="User:Kcordina">Kcordina</a>, <a href="../../../s/l/i/User%7ESliggy_825f.html" title="User:Sliggy">Sliggy</a>, <a href="../../../d/o/n/User%7EDonbert_a4e6.html" title="User:Donbert">Donbert</a>, <a href="../../../p/b/e/User%7EPbevin_93fa.html" title="User:Pbevin">Pbevin</a>, Masterleep, Hyperfusion, BethBukata, <a href="../../../b/u/b/User%7EBubba73_9231.html" title="User:Bubba73">Bubba73</a>, <a href="../../../b/o/m/User%7EBomac_e7d7.html" title="User:Bomac">Bomac</a>, <a href="../../../t/h/a/User%7EThat_Guy%2C_From_That_Show%21_4388.html" title="User:That Guy, From That Show!">That Guy, From That Show!</a>, <a href="../../../b/i/l/User%7EBilransom_985f.html" title="User:Bilransom">Bilransom</a>, <a href="../../../m/s/l/User%7EMsleeman_c056.html" title="User:Msleeman">Msleeman</a>, <a href="../../../r/a/s/User%7ERasmus_Faber_cecb.html" title="User:Rasmus Faber">Rasmus Faber</a>, <a href="../../../j/o/e/User%7EJoelmills_0f99.html" title="User:Joelmills">Joelmills</a>, <a href="../../../k/o/s/User%7EKosebamse_5238.html" title="User:Kosebamse">Kosebamse</a>, Cafedumonde, <a href="../../../g/u/a/User%7EGuanaco_98c8.html" title="User:Guanaco">Guanaco</a>, CANCEROUS, <a href="../../../a/d/r/User%7EAdrian_9077.html" title="User:Adrian">Adrian</a>, <a href="../../../d/a/n/User%7EDaniel_Case_1b0d.html" title="User:Daniel Case">Daniel Case</a>, <a href="../../../u/g/u/User%7EUgur_Basak_b749.html" title="User:Ugur Basak">Ugur Basak</a>, <a href="../../../c/r/o/User%7ECroat_Canuck_c04a.html" title="User:Croat Canuck">Croat Canuck</a>, <a href="../../../f/l/y/User%7EFlyguy649_8ae4.html" title="User:Flyguy649">Flyguy649</a>, <a href="../../../f/o/l/User%7EFolajimi_dee8.html" title="User:Folajimi">Folajimi</a>, <a href="../../../j/o/a/User%7EJoanneB_e69b.html" title="User:JoanneB">JoanneB</a>, <a href="../../../a/e/d/User%7EAED_76b1.html" title="User:AED">AED</a>, <a href="../../../j/k/a/User%7EJkatzen_b037.html" title="User:Jkatzen">Jkatzen</a>, <a href="../../../k/a/h/User%7EKahlen_660b.html" title="User:Kahlen">Kahlen</a>, <a href="../../../x/a/o/User%7EXaosflux_5b5b.html" title="User:Xaosflux">Xaosflux</a>, <a href="../../../r/e/b/User%7ERebelguys2_63db.html" title="User:Rebelguys2">Rebelguys2</a>, <a href="../../../w/e/l/User%7EWelsh_c865.html" title="User:Welsh">Welsh</a>, HistoryBA, <a href="../../../w/h/o/User%7EWho_d957.html" title="User:Who">Who</a>, <a href="../../../b/r/i/User%7EBrim_2417.html" title="User:Brim">Brim</a>, <a href="../../../r/e/b/User%7ERebrane_d41b.html" title="User:Rebrane">Rebrane</a>, <a href="../../../c/t/a/User%7ECtande_85e3.html" title="User:Ctande">Ctande</a>, <a href="../../../c/h/r/User%7EChrisRuvolo_a573.html" title="User:ChrisRuvolo">ChrisRuvolo</a>, <a href="../../../k/w/i/User%7EKwi_d01c.html" title="User:Kwi">Kwi</a>, Jack Wallington, <a href="../../../m/a/t/User%7EMatt.whitby_7a04.html" title="User:Matt.whitby">Matt.whitby</a>, <a href="../../../d/i/s/User%7EDismas_8600.html" title="User:Dismas">Dismas</a>, Amber56, <a href="../../../t/i/m/User%7ETimwi_eb8f.html" title="User:Timwi">Timwi</a>, <a href="../../../s/o/c/User%7ESocratesJedi_4545.html" title="User:SocratesJedi">SocratesJedi</a>, <a href="../../../y/o/s/User%7EYosri_d93e.html" title="User:Yosri">Yosri</a>, <a href="../../../s/u/p/User%7ESupercool_Dude_cf24.html" title="User:Supercool Dude">Supercool Dude</a>, <a href="../../../r/e/i/User%7EReinyday_5c19.html" title="User:Reinyday">Reinyday</a>, <a href="../../../f/l/a/User%7EFlaBot_747f.html" title="User:FlaBot">FlaBot</a>, Markellogg, GusV, <a href="../../../n/i/k/User%7ENiki_K_cae0.html" title="User:Niki K">Niki K</a>, <a href="../../../h/a/d/User%7EHadal_a4d0.html" title="User:Hadal">Hadal</a>, Fuzz, <a href="../../../w/e/f/User%7EWeft_6182.html" title="User:Weft">Weft</a>, <a href="../../../j/o/y/User%7EJoy_7c18.html" title="User:Joy">Joy</a>, <a href="../../../t/r/u/User%7ETruthflux_0692.html" title="User:Truthflux">Truthflux</a>, <a href="../../../c/d/c/User%7ECdc_936f.html" title="User:Cdc">Cdc</a>, <a href="../../../e/s/p/User%7EEsparkhu_d424.html" title="User:Esparkhu">Esparkhu</a>, <a href="../../../c/h/i/User%7EChinasaur_7224.html" title="User:Chinasaur">Chinasaur</a>, <a href="../../../d/e/n/User%7EDennis_Valeev_c2cf.html" title="User:Dennis Valeev">Dennis Valeev</a>, <a href="../../../r/o/b/User%7ERobbot_3bd9.html" title="User:Robbot">Robbot</a>, <a href="../../../m/p/i/User%7EMpiff_fa5a.html" title="User:Mpiff">Mpiff</a>, Indranil, <a href="../../../w/a/r/User%7EWarfieldian_373f.html" title="User:Warfieldian">Warfieldian</a>, World4health, <a href="../../../k/d/4/User%7EKd4ttc_9614.html" title="User:Kd4ttc">Kd4ttc</a>, <a href="../../../p/h/e/User%7EPhe_0829.html" title="User:Phe">Phe</a>, <a href="../../../a/l/e/User%7EAlex.tan_6c56.html" title="User:Alex.tan">Alex.tan</a>, <a href="../../../c/r/y/User%7ECryptoDerk_6aa9.html" title="User:CryptoDerk">CryptoDerk</a>, <a href="../../../w/e/b/User%7EWebkid_271c.html" title="User:Webkid">Webkid</a>, Georgec, <a href="../../../a/n/k/User%7EAnkur_0fc1.html" title="User:Ankur">Ankur</a>, <a href="../../../w/h/i/User%7EWhisperToMe_201b.html" title="User:WhisperToMe">WhisperToMe</a>, <a href="../../../w/i/k/User%7EWikibot_9002.html" title="User:Wikibot">Wikibot</a>, <a href="../../../p/e/a/User%7EPeak_ed3e.html" title="User:Peak">Peak</a>, <a href="../../../a/n/d/User%7EAndre_Engels_23d0.html" title="User:Andre Engels">Andre Engels</a>, <a href="../../../e/d/_/User%7EEd_Poor_ed4e.html" title="User:Ed Poor">Ed Poor</a>, <a href="../../../g/g/a/User%7EGGano_e118.html" title="User:GGano">GGano</a>, <a href="../../../m/y/r/User%7EMyRedDice_bcb5.html" title="User:MyRedDice">MyRedDice</a>, <a href="../../../m/a/v/User%7EMaveric149_24ee.html" title="User:Maveric149">Maveric149</a> and <a href="../../../v/i/c/User%7EVicki_Rosenzweig_719b.html" title="User:Vicki Rosenzweig">Vicki Rosenzweig</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
